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Abstract 
The hybridization of magnetic resonance imaging (MRI) and positron emission tomography 
(PET) provides the benefit of soft-tissue contrast and specific molecular information in a 
simultaneous acquisition.  The applications of PET-MRI in radiotherapy are only starting to 
be realised. However, quantitative accuracy of PET relies on accurate attenuation correction 
(AC) of, not only the patient anatomy but also MRI hardware and current methods, which are 
prone to artefacts caused by dense materials.  Quantitative accuracy of PET also relies on full 
characterization of patient motion during the scan. The simultaneity of PET-MRI makes it 
especially suited for motion correction.  However, quality assurance (QA) procedures for 
such corrections are lacking. Therefore, a dynamic phantom that is PET and MR compatible 
is required.  Additionally, respiratory motion characterization is needed for conformal 
radiotherapy of lung.  4D-CT can provide 3D motion characterization but suffers from poor 
soft-tissue contrast.  In this thesis, I examine these problems, and present solutions in the 
form of improved MR-hardware AC techniques, a PET/MRI/CT-compatible tumour 
respiratory motion phantom for QA measurements, and a retrospective 4D-PET-MRI 
technique to characterise respiratory motion. 
Chapter 2 presents two techniques to improve upon current AC methods that use a 
standard helical CT scan for MRI hardware in PET-MRI. One technique uses a dual-energy 
computed tomography (DECT) scan to construct virtual monoenergetic image volumes and 
the other uses a tomotherapy linear accelerator to create CT images at megavoltage energies 
(1.0 MV) of the RF coil.  The DECT-based technique reduced artefacts in the images 
translating to improved μ-maps. The MVCT-based technique provided further improvements 
in artefact reduction, resulting in artefact free μ-maps.  This led to more AC of the breast 
coil. 
In chapter 3, I present a PET-MR-CT motion phantom for QA of motion-correction 
protocols. This phantom is used to evaluate a clinically available real-time dynamic MR 
images and a respiratory-triggered PET-MRI protocol. The results show the protocol to 
perform well under motion conditions. Additionally, the phantom provided a good model for 
performing QA of respiratory-triggered PET-MRI. 
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Chapter 4 presents a 4D-PET/MRI technique, using MR sequences and PET 
acquisition methods currently available on hybrid PET/MRI systems.  This technique is 
validated using the motion phantom presented in chapter 3 with three motion profiles. I 
conclude that our 4D-PET-MRI technique provides information to characterise tumour 
respiratory motion while using a clinically available pulse sequence and PET acquisition 
method.   
Keywords 
Hybrid Imaging, positron emission tomography (PET), magnetic resonance imaging (MRI), 
attenuation correction, megavoltage computed tomography (MVCT), dual-energy computed 
tomography (DECT), quality assurance (QA), respiratory motion, phantom, motion-
correction, four dimensional positron emission tomography magnetic resonance imaging 
(4D-PET/MRI). 
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Chapter 1  
1 Introduction 
The effectiveness of cancer treatment is increasingly dependent on imaging for diagnosis, 
intervention planning, and assessment of treatment response.  Among the modalities 
commonly used for intervention planning, X-ray Computed Tomography (CT) is the 
standard of care and the basis from which nearly all radiotherapy treatments are planned.  
Complementary to CT, which provides detailed anatomical information about therapy 
targets and surrounding tissues, Positron Emission Tomography (PET) can provide 
biological information through the visualization of radiotracer distribution within the 
patient.  The hybridization of these two modalities as PET-CT has not only become a 
powerful tool in cancer detection but also allows for improved target volume definition 
when used in radiotherapy planning.  Magnetic Resonance Imaging (MRI) has also been 
increasingly used in radiotherapy treatment planning due to its superior soft-tissue 
contrast, and in recent years, its hybridization with PET has attracted the attention of the 
radiation oncology community.  As with most new technologies, work with PET-MRI is 
an ongoing area of research in an effort to improve, and expand its applications.  This 
thesis examines several methods to improve the utility of PET-MRI for radiotherapy 
treatment planning applications.  The work herein includes a description and comparison 
of CT-based techniques to correct PET signal attenuation due to the presence of MRI 
radiofrequency coils, the development of a PET/MRI/CT-compatible tumour respiratory 
motion phantom for use in quality assurance and/or development of protocols designed to 
correct or characterize respiratory motion, and lastly, the description and evaluation of a 
four-dimensional (4D) PET-MRI technique for the characterization of tumour motion 
that can complement 4D-CT based radiation treatment planning.  In this first chapter, I 
will discuss the principles of each imaging modality used in subsequent chapters, some 
of the challenges associated with the hybridization of those modalities including issues 
related to attenuation correction, investigate various techniques used to mitigate the 
effects of motion during imaging, techniques used to characterize motion, and provide 
some motivation behind this work.  Finally, I will provide an overview of the thesis 
itself. 
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1.1 Computed Tomography Principles 
X-ray computed tomography (CT) is a non-invasive high-resolution anatomic imaging 
modality that has been commonly used for clinical diagnostic purposes since the early 
1970’s.  Today it is among the most important imaging technologies for both oncologic 
diagnosis and intervention planning.  In a technique described by Hounsfield in 1972, 
and later by Ambrose in 1973, a CT scanner uses a rotating x-ray source to take 
attenuation measurements over a large number of angles to reconstruct a two-
dimensional (2D) cross-sectional image, usually in the transverse plane.1,2 The CT 
scanner acquires many of these image sections of a patient, usually in the longitudinal 
direction, to construct a three-dimensional (3D) image volume of the patient’s internal 
organs.  Comprehensive technical descriptions of CT scanners can be found in various 
scientific publications and textbooks.3,4 
1.1.1 CT Artefacts and Reduction Techniques 
In general terms, an image artefact is any feature within an image that is not present in 
that actual subject being imaged.  In CT, there are many different sources of artefacts, all 
of which may mimic or obscure pathology.  Fortunately, the mechanisms behind these 
artefacts have been studied and methods for avoidance and reduction can be taken to 
ensure good quality images.  The majority of CT artefacts can be grouped into one of 
four categories, based on their source: Hardware-based, reconstruction-based, patient-
based, and physics-based.  The next four sub-sections will describe the various artefacts 
that can be derived from these sources, the mechanisms behind each of these, and 
strategies designed to avoid or reduce their presence in images. 
1.1.1.1 Hardware-based Artefacts 
Ring artefacts are characterized by rings of dark or bright voxels centered on the point of 
rotation of the CT gantry.  This is caused by a defective or uncalibrated detector on a 
third generation scanner and is more likely to be visible through a uniform medium like 
air or a uniform phantom.  Although ring artefacts are less visible against the 
heterogeneity of clinical scans, their presence is more likely to negatively impact the 
diagnostic quality of the image rather than be mistaken for disease (Figure 1-1). These 
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artefacts can be avoided with a calibration scan and adjusting the detector gain to match 
the other detectors.  In the case where calibrations fail, repairing or replacing the faulty 
detector should solve the problem.   
 
Figure 1-1: Ring artefact in a pelvic CT. Image was adapted from Boas et al. 
(2012).5  
1.1.1.2 Reconstruction-based Artefacts 
In a helical CT scan, the reconstruction process involves a helical interpolation.  In a 
single-row detector system, when a high contrast edge falls between two acquired image 
slices, the reconstruction algorithm alternates between measurements from a single 
acquired row and interpolated values between two acquired rows all while the table is 
advancing during the scan.  Some projection angles have greater contributions from the 
high-density feature, while other angles have more contributions from the low-density 
feature.  This results in alternating light and dark bands radiating outwards from the 
center of the transverse image.  If you are to scroll through the image slices, these bands 
will appear to rotate, giving them their name ‘windmill artefacts’. In a multi-row detector 
CT, this interpolation process can complicate windmill artefacts even further. This is 
because there is now the potential for several detector rows to fall on that high contrast 
edge during gantry rotation. A higher scan pitch results in more radial bands because 
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more detector rows cross the high contrast edge during a rotation.  Therefore, lowering 
the pitch, using a 180-degree versus a 360-degree interpolation, or using thinner 
acquisition slices can minimize windmill artefacts.   
Cone beam artefacts are also reconstruction-based.  As the number of detector 
rows acquiring data during a scan increases, as in the case of cone beam, wider 
collimation is required.  However, the collected data is no longer contained within a flat 
plane.  Instead, it is contained within the intersecting volume between cones.  Features 
located further from the central axis experience artefacts that are similar to partial 
volume.  This increases in detectors located in the outer rows, where x-rays detected 
correspond less with their planar location.  Although reconstructions will require more 
time, using appropriate multi-row detector geometry within a specific cone beam 
reconstruction strategy, rather than a standard reconstruction technique, can reduce 
resulting artefacts. 
Stair step artefacts appear as serrations at the edges of structures on coronal or 
sagittal CT images.  Although less severe in helical scans, stair step artefacts can occur in 
multi-row and 3D reformatted images within non-overlapping reconstruction intervals of 
scans using wide collimators.  Today’s multi-row CTs have greatly reduced stair step 
artefacts due to the thinner sections of data that are acquired. 
Another artefact that can result from the helical interpolation process is zebra 
artefact.  This appears as faint alternating stripes of more or less noise along the z-
direction of the image and is more pronounced along the outer portions of the image as 
you move away from the rotation axis of the CT.  Again, this type of artefact can be 
reduced with thinner sectioned data acquisition.  Figure 1-2 highlights the various types 
of CT reconstruction-based artefacts. 
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Figure 1-2: Reconstruction-based artefacts. A) Windmill artefact streaks around 
cholecystectomy clips. Image adapted from Boas et al. (2012),5 B) Cone beam 
artefacts shown around a Teflon rod positioned with a 70 mm offset form scanner 
isocenter, C) Stair step artefact in a sagittal reformatted image from an axial CT 
with 5 mm collimation and reconstruction interval, D) Zebra artefacts shown in a 
maximum intensity projection image from a thoracic helical CT.  Images for B-D 
adapted from Barrett et al. (2004).6  
1.1.1.3 Patient-based Artefacts 
Incomplete projections cause shading or streaking artefacts across the transverse plane of 
CT images.  This patient-based artefact happens when part of the patient lies outside of 
the scanner’s field of view (FoV).  Incomplete projections can also be caused by highly 
attenuating items such as equipment coming in between the beam and detectors of the CT 
during a scan.  Although this can be resolved by ensuring that no patient parts lay outside 
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the FoV or equipment lay in the beam’s path, some scanners are able to detect 
inconsistencies in reference data channels to avoid using suspicious reference data.  
Some systems are also designed with reference detectors on the tube side (or ray path 
within the gantry) to eliminate any interference with reference data.6  
Patient motion is another potential source of artefact in CT.  Some patient motion 
can be avoided through shortened scan times, immobilization devices, and in some cases 
sedation.  However, some motion is involuntary and cannot be avoided during a scan.  
This results in slice misregistration artefacts appearing as streaks or shading throughout 
the image.  Some CT scanners have built-in motion artefact reduction features.  Some of 
these features involve either scanning more than 360 degrees of a bed position or 
excluding some of the CT projections from the reconstruction to either average out the 
motion or exclude projections with the maximum discrepancy respectively.  Some 
systems also make use of gating to capture a single phase of the cardiac or respiratory 
cycle.  I will explore more of these motion management methods in the context of 
radiotherapy planning in section 1.5.1.1.  Figure 1-3 highlights examples of patient-based 
CT artefacts. 
 
Figure 1-3: Patient-based artefacts. A) Streaking artefact in CT from incomplete 
projections caused by patient’s arms being placed at their side but outside the FoV. 
B) Motion artefact caused by respiration during CT scan. Images adapted from 
Barrett et al. (2004).6  
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It is not uncommon for a patient to have metal on or inside of them.  Whether in 
the form of an aneurism clip, artificial joint or dental implant, metal produces artefacts in 
CT images that appear as bright and dark streaks projecting outward from the metal 
object.  This is caused by the metal’s density, which lay outside of the normal range that 
the CT system was designed to calculate. In some cases, metal can be removed from the 
FoV, and some scanners are equipped with metal artefact reduction software.7 This 
software may reduce or remove the streaks associated with metal but often at the cost of 
losing detail locally.  Even though metal artefacts can often be considered a patient-based 
problem, the mechanisms by which they occur are physics-based.  I examine some of 
these mechanisms of metal artefact in more detail in the following section, 1.1.1.4. 
1.1.1.4 Physics-based Artefacts 
Aside from the averaging of CT number values of materials within a single voxel, partial 
volume effect can result in shading artefacts caused by inconsistencies between detector 
views.  This happens when an object lies within the beam at one point of rotation, but 
outside of the beam at the opposite point of rotation.  Fortunately, this type of artefact 
can be avoided by acquiring with thin acquisition sections. 
Photon starvation occurs in highly attenuating regions within a patient’s body or 
with certain dense materials.  The inadequate number of photons making their way 
through the object to the detectors causes noisy projections, making streaks in the 
images.  Increasing the tube current can minimize this particular artefact.  However, a 
consequence of increasing tube current is an increased patient dose from the x-ray beam.  
To avoid increasing current, some CTs are capable of automatically varying the tube 
current in a process called milliamperage modulation.  Another method to reduce 
artefacts from photon starvation is through adaptive filtration.  Here software is used to 
smooth attenuation profiles in areas that are highly attenuated prior to image 
reconstruction. 
Another physics-based artefact can result from undersampling.  This can happen 
when intervals between projections are too large, causing view aliasing appearing as thin 
stripes projecting at a distance from the object. Undersampling can also cause ray 
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aliasing, which appears as stripes that are close to the object being imaged.  View 
aliasing can be resolved by increasing the number of projections per rotation and ray 
aliasing can be resolved by increasing resolution through methods like quarter-detector 
shift or flying focal spot.  Figure 1-4 highlights streaking artefacts and aliasing in CT.  
 
Figure 1-4: A) Streaking artefacts caused by photon starvation in CT of shoulder 
phantom, B) Arrow pointing to aliasing caused by undersampling in CT of Teflon 
block phantom in water. Images adapted from Barrett et al. (2004).6  
The final type of physics-based artefact I will discuss happens as a beam passes 
through a medium and lower energy photons are absorbed more readily than higher 
energy photons.  This causes the mean beam energy to increase, in other words get 
‘harder’.  This causes cupping artefacts and/or dark streaks to appear to be projecting 
from dense objects, which can be seen in Figure 1-5.  Cupping can occur in objects with 
rounded cross-sectional profiles.  The edge of the object will often have a higher CT 
number than the middle of the object, even when it may be composed of homogenous 
material.  This is now typically corrected with a simple beam hardening correction, 
commonly built into current CT systems.  Streaking artefacts from beam hardening can 
occur in bone, contrast medium, or in other highly attenuating materials.  This can be 
improved with the use of filtration, calibration correction, or beam hardening correction 
software.  Filtration is used to harden the beam prior to it passing through the object of 
interest.  This is often accomplished with a metallic filter.  Bow tie filters can also be 
used to harden just the edges of a beam, which pass through the thinner anatomy of a 
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patient.  Calibration correction is used to determine an appropriate compensation for 
anatomy specific scans.  Beam hardening correction software uses an iterative approach 
to reduce dark bands and blurring in soft-tissue/bone interfaces.  This is primarily used 
when imaging bony anatomy.  However, the above strategies are often insufficient when 
attempting to correct for materials with much higher electron densities like metals.  One 
method to reduce the effects of beam hardening from materials with densities greater 
than bone is by scanning with two different energy spectra, using a dual energy CT 
(DECT) scanner.  Information taken from the two energy spectra can be used to calculate 
virtual monochromatic images of the subject, which have substantially reduced beam-
hardening artefacts.  Another method of reducing the effects of beam hardening from 
materials with densities greater than bone is to make the beam itself harder, or in other 
words, scan at higher energies. These higher energy photons are less likely to be 
absorbed by high atomic number objects, resulting in reduced artefacts.  A third method 
to reduce streaking artefacts in CT, caused by high-density materials is iterative 
reconstruction.  I explore both DECT and imaging with higher energy x-rays in the 
following two sections, followed by a very brief section on the use of iterative 
reconstruction techniques for metal artefact reduction in CT. 
 
Figure 1-5: Physics-based artefacts. A) Cupping artefact due to beam hardening in 
CT image of cylindrical uniform water phantom. Adapted from Barrett et al. 
(2004),6 B) Streaking due to beam hardening in CT image of hip replacements. 
Adapted from Boas et al. (2012).5  
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1.1.2 Dual-energy Computed Tomography (DECT) 
DECT uses two different photon energy spectra, each composed of a bremsstrahlung 
spectra and characteristic peaks of target materials, with maximum photon energy being 
determined by the x-ray tube voltage.  Although dual-energy images can be acquired 
sequentially, by either taking two separate helical scans at different voltages or single 
rotations at alternating tube voltages, several manufacturers have taken various design 
approaches to achieving DECT in a timelier and less motion artefact prone way.  Some 
systems use a single x-ray tube and achieve two different energy spectra by quickly 
switching between low and high voltages.8-10 Another approach often referred to as dual-
source CT (DSCT), involves a CT gantry equipped with two detector arrays and two x-
ray tubes operating at two different voltages.11,12 To minimize the amount of spectral 
overlap when using standard x-ray tubes, 80 and 140 keV are the most commonly used 
energies in DECT.  In DSCT scanners, this spectral overlap can be further minimized 
with the use of tin filters.  Figure 1-6 characterizes DECT and DSCT. 
 
Figure 1-6: Dual-energy CT source configurations. A) Single tube configurations 
rapidly switch between low and high voltages, B) Dual-source CT configurations 
use two separate x-ray tubes, operating at different voltages to achieve dual-energy 
imaging.13 
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Data acquired at two different tube potentials allows us to extract various forms 
of spectral information, depending on the type of post-processing used.  The most 
common approach is to first reconstruct the CT images from each energy dataset.  
Spectral information can then be extracted based on differences calculated from the two 
image sets.  There are mainly three types of information that are extracted with these 
image-based algorithms: material differentiation, material quantification, and image 
optimization. 
Algorithms used to differentiate specific materials like calcium and magnesium 
from uric-acid, as in the case of locating kidney stones, are based on the photoelectric 
effect within specific density ranges.  Here, a slope is defined between density values at 
each spectra and a different colour is assigned to either side of the slope.14-16 
Quantifying a substance, such as contrast medium, within an image volume can 
also be calculated. This can be achieved using an algorithm called ‘three material 
decomposition’.  Density measurements can be interpreted as a value’s displacement 
from normal tissue densities in relation to values defined by the photoelectric effect of 
the contrast material used.17-19 
The third type of post-processing algorithm is used for image optimization.  One 
type of image optimization is called nonlinear blending.  This algorithm creates an 
optimum contrast image by combining high iodine contrast with low noise.20 Another 
image optimization algorithm is able to calculate virtual monoenergetic image volumes 
from the manipulation of either projection data21 or image data22 from each of the two 
energy spectrums.  This technique is particularly useful for reducing beam-hardening 
artefacts in images containing materials with higher electron densities like iodinated 
contrast agents.23  
1.1.3 Megavoltage Computed Tomography (MVCT) 
As mentioned previously, one method of reducing CT artefacts produced from high-
density materials is to make the beam itself harder, or in other words increase the average 
energy of the x-ray beam.  Work by Schreiner et al. shows that higher energy photons 
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emitted from Cobalt-60 source (𝛾𝐶𝑜−60 = 1.25 MeV) and a linear accelerator (linac) 
(mean x-ray = 1.3 MeV) are not as susceptible to absorption through photoelectric effect. 
Instead, photons at megavoltage energies are more likely to interact with high-density 
material through Compton scattering, providing better photon penetration.  This results in 
images that are less artefact prone than images produced in the kilovoltage energy 
range.24 It was also noted that MVCT images show a linear relationship between the 
Hounsfield values of the imaging volumes and the electron densities of the corresponding 
materials in those volumes (Figure 1-7).25  
 
Figure 1-7: Plot showing linear relationship between the electron densities of 
various high-density materials and their respective CT numbers from MVCT 
images.  Adapted from Rogers et al. (2005).25  
A helical tomotherapy unit (Accuray Inc., Sunnyvale, CA) has a 6 MV linac 
mounted opposite to a detector array, on a ring gantry. The ring gantry assembly rotates 
continuously while the patient couch translates through the gantry.  Work done by 
Yartsev et al. shows how this same unit can be used for the acquisition of MVCT images 
with the linac detuned, reducing its mean energy to 1.0 MeV.26  
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1.1.4 Iterative Reconstruction (IR) for CT Metal Artefact Reduction 
High-density materials, such as metals, cause a lack of projection data due to high photon 
absorption, particularly of the lower energy photons in the x-ray spectrum.27-30 This 
produces a corrupted sinogram, which is missing data.  The common CT reconstruction 
technique is an analytical algorithm called filtered back-projection (FBP).  FBP is not 
designed to account for these inconsistencies in the data.  Several algorithms have been 
proposed to reduce these streaking artefacts caused by metal, and have had limited 
success.27-31 These methods attempt to repair the corrupted sinogram data through 
replacing with intact data or a linear interpolation through the corrupt region. 
Interestingly, iterative reconstruction (IR) algorithms have been around for many 
years in CT but due to the higher computational demands of IR compared to analytical 
methods like FBP, were abandoned when the volume of data increased.  More recently, 
the availability of powerful computing resources has helped bring about renewed interest 
in IR techniques for quality improvement of CT images,32-34 dose reduction, and artefact 
reduction.35,36 IR techniques inherently perform better at metal artefact reduction than 
analytical techniques because IR methods approach a solution to fit the data that was 
measured, whereas FBP assumes the measured data is complete and exact.  This 
assumption cannot be made when imaging in the presence of metal.  However, due to 
limited clinical availability, IR is seldom used. 
1.2 MRI Principles 
Despite the widely adopted applications of CT, MRI provides much greater soft-tissue 
contrast.  MRI allows tissues to be imaged with a wide variety of contrast mechanisms, 
from both endogenous tissue properties and exogenous contrast mediums.  Figure 1-8 
highlights the superior soft-tissue contrast of MRI over CT, using three different contrast 
mechanisms.  The differences in CT and MR images arise from the different contrast 
mechanisms they use.  Where CT images are based solely on electron densities, MR 
images are based on subtle changes in magnetic relaxation within tissues.  More 
specifically, MRI most often relies on the signal derived from hydrogen nuclei (protons) 
within tissues as they interact with magnetic fields and radiofrequency (RF) pulses.  The 
14 
 
basic principles of how these interactions are used to create images are discussed in the 
subsequent six sections.  
 
Figure 1-8: Axial images of an anaplastic medulloblastoma in A) noncontrast CT, 
B) T2-weighted MRI, C) T1-weighted MRI, and D) contrast-enhanced T1-weighted 
MRI. Adapted from Eran et al. (2010).37  
1.2.1 Magnetic Moment 
Hydrogen protons are frequently used as the basis for MR images because of their 
abundance in tissues and their strong magnetic moment.  For simplicity, I will describe 
the motion of these magnetic moments using classical mechanics. The strong magnetic 
moment is due to the spin of this positively charged particle, the proton.  The strength of 
a proton’s magnetic moment is proportional to its angular momentum as it spins around 
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an internal axis.  At this level, each proton acts like a very small magnetic bar with a 
north and south-pole.  Ordinarily, the magnetic moments of protons in tissues are 
oriented in random directions.  The result is no net magnetization.  However, when a 
strong external magnetic field is applied the protons will begin to precess about the 
direction of the applied external magnetic field in either a parallel or antiparallel state.  
These states only refer to the longitudinal components of a proton’s magnetic moment 
and the relative proportion of each state is dependent upon the magnitude of the applied 
external magnetic field.  The Larmor frequency, or in other words the frequency with 
which the protons precess is directly proportional to the strength of the external magnetic 
field according to the equation, 
 𝜔 =  𝛾Β0, (1) 
where 𝛾 is the gyromagnetic ratio, which is equal to 42.576 MHz/Tesla for hydrogen 
protons, and Β0 is the strength of the external magnetic field.  Thus, in a 3 Tesla 
magnetic field the precession frequency of hydrogen protons will be ≈ 128 MHz. 
The total magnetization from all proton magnetic moments within tissues can be 
represented as a simple vector that has only a net longitudinal component. 
1.2.2 Radiofrequency Pulses and Magnetization 
The detection of MRI signal is made possible by exploiting the resonant absorption and 
dissipation of energy.  The resonant absorption of energy is achieved through the 
transmission of RF electromagnetic field pulses or excitation pulses.  The frequency of 
this RF field pulse must be identical to the precession frequency of the protons, which is 
calculated using the Larmor formula, shown as equation 1 in section 1.2.1.  The RF field 
causes the net magnetization to rotate into the transverse plane and away from the 
longitudinal direction of the main external magnetic field.  The strength and duration of 
the RF field pulse will determine the amount of rotation, or flip angle, of the net 
magnetization.   
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1.2.3 Detection of MR Signal 
This transverse component of the magnetic precession is responsible for the detectable 
signal, which is captured by the MRI receiver coils.  The MRI receiver coils are 
essentially a pair of electrically conductive loops that are placed within close proximity 
to the patient and behave as the ‘antenna’ of the MRI system.  A voltage is induced in the 
receiver coils as the protons in the patient’s tissues relax from their transverse 
magnetization back to their equilibrium state along the direction of the main magnetic 
field.  
1.2.4 MR Relaxation 
The equilibrium state of protons while in the main magnetic field has only a net 
longitudinal component.  In this state, the net transverse component is equal to zero.  
When the RF pulse is applied, the energy added to the protons’ spin states pushes it out 
of equilibrium, increasing the transverse component of magnetization.  When the RF 
pulse is stopped, their spins relax back to their equilibrium state through the gradual 
decay of the transverse component.  MR relaxation is the combination of two different 
mechanisms, the recovery of the longitudinal magnetization (T1) and the decay of the 
transverse magnetization (T2) caused by the dephasing of spins.  These T1- and T2-
relaxation times differ between tissues types, both healthy and diseased.  It is these 
differences that form the basis for contrast in MR images. 
1.2.5 Image Acquisition and Spatial-encoding 
As mentioned in section 1.2.2, the resonant absorption of energy is achieved through the 
transmission of RF pulses at a frequency that is equal to the precession frequency of the 
protons in the subject being imaged.  When a patient is placed within the main magnetic 
field, every proton within the patient’s tissues that lay within the MRI’s field of view has 
the same precession frequency.  As such, there is no spatial information about the signals 
being received during the protons’ relaxation. 
Gradient coils are used to spatially-encode these signals through the application 
of time and spatially varying magnetic fields in addition to the already present static main 
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magnetic field (Figure 1-9).  The dynamic application of these spatially varying magnetic 
fields is made possible by three sets of gradient coils, each corresponding to one of the 
main orthogonal directions.  Gradient coils are designed to produce a linear spatial 
variation of the magnetic field, which in turn creates spatial variation of resonant 
frequencies.  Each of the magnetic field gradients is positioned such that there is no 
additional contribution to the main field at the isocenter (x=0, y=0, z=0).  Here, the x-
axis represents the left/right direction, y-axis the anterior/posterior direction, and z-axis 
the superior/inferior direction.  Gradient coils and the magnetic field gradients they 
create help to facilitate the three major processes of forming an image dataset.  These 
processes are slice selection, phase-encoding, and frequency-encoding. 
 
Figure 1-9: Simplified configuration of gradient coils for the three main orthogonal 
directions, A) x-gradient coils, B) y-gradient coils, C) z-gradient coils, and D) all 
three sets of coils. 
Slice selection is the process of selectively exciting protons that lie within a 
desired slice of a sample/patient.  Selective excitation is achieved by applying a gradient 
magnetic field orthogonal to the desired slice.  At the same time, the excitation pulse is 
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applied with a frequency that matches the precession frequency of the protons in the 
desired slice.  The precession frequency of this slice (𝜔𝑆𝑙𝑖𝑐𝑒) is given by: 
 𝜔𝑆𝑙𝑖𝑐𝑒 =  𝛾(𝐵0  +  𝑧𝐺𝑆𝑙𝑖𝑐𝑒) , (2) 
where 𝐺𝑆𝑙𝑖𝑐𝑒 is the strength of the gradient magnetic field at the position 𝑧 of our slice.  
Within this slice, the two remaining spatial axes can be encoded by using phase-encoding 
and frequency-encoding. 
The process of phase-encoding requires the application of a second linear 
gradient magnetic field along one of the two remaining directions within the slice plane 
after the excitation pulse.  This phase-encoding gradient (GPhase) is applied only briefly, 
causing a spatially dependent phase shift along the direction of the applied gradient.   A 
different intensity phase-encoding gradient must be applied after each excitation pulse 
and a separate excitation pulse must be applied for each row of voxels in the phase-
encoding direction.  To ensure an adequate amount of longitudinal relaxation occurs 
between excitation pulses, a delay called the repetition time (TR) is included.  The TR 
multiplied by the number of phase-encoding steps defines the total time needed to 
acquire an image. 
The final spatial dimension is encoded by applying a third linear gradient 
magnetic field while acquiring data.  Similar to how the slice selection gradient creates a 
spatially dependent variation of proton precession frequencies during excitation, the 
frequency-encoding gradient (GFrequency) creates a spatially dependent variation of proton 
precession frequencies in the frequency-encode direction while receiving the RF signal.  
A simple pulse diagram of a gradient echo sequence shows each of the above-
described events in relation to each other over time (Figure 1-10).  The sequence of RF 
excitation pulses and magnetic field gradients combine to produce an image where each 
voxel can be characterized by a specific phase and frequency within the selectively 
excited sample/patient slice.   
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Figure 1-10: A gradient echo pulse sequence diagram. The horizontal axis shows the 
timing of basic hardware activity as they are incorporated into the pulse sequence. 
To reconstruct a 2D image from of the selected slice, a Fourier transform is used 
to convert the frequency-encoded data into frequency projects.  Those frequency 
projections are then converted into the final 2D image by applying second Fourier 
transform. 
1.3 PET Principles 
Positron emission tomography (PET) is a nuclear medicine, molecular imaging technique 
used to track and quantify the distribution of molecular processes in the body.  This is 
achieved by injecting a positron-emitting radioactive tracer into a patient.  Tracers are 
often designed to have specific biological interactions, which influence the distribution of 
the tracer throughout the body.  For example, 18F-fluorodeoxyglucose (18F-FDG) is a 
tracer in the form of a glucose analogue.  18F-FDG can be used to image the distribution 
of tissue metabolism throughout a patient’s body based on its correlation with glucose 
uptake.  This tracer is most commonly used for cancer imaging.  The hypermetabolic 
properties of cancer cells cause 18F-FDG to accumulate in tumours.  The positrons 
emitted from PET tracers annihilate with electrons within the patient’s tissues.  Each of 
these annihilations results in the emission of two 511 keV gamma-photons in opposing 
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directions and it is these gamma-photons that are detected by the PET scanner.38 One of 
the main strengths of PET is its sensitivity.  Although PET typically measures 
radiotracers in nanomolar concentrations, it is possible to measure radiotracers present in 
picomoles.39  
A PET scanner has detector blocks that are designed to detect these 511keV 
photons.  Each detector block consists of an inorganic scintillator crystal attached to an 
array of photomultiplier tubes (PMTs).  Circular arrays or axially stacked rings of 
detector blocks within the PET scanner face inwards to surround an imaging volume (see 
Figure 1-11). 
 
Figure 1-11: A typical arrangement of detector blocks in a PET scanner.  Inset 
upper left corner, is an example of a detector block configuration with scintillator 
crystal and PMTs.  Inset bottom right corner, shows the beta+ decay of a 
radioactive isotope, the path of the emitted positron, and its annihilation with an 
electron, which results in the emission of two gamma photons. 
21 
 
The scintillator crystal of the detector block absorbs the gamma-photons and 
through the photoelectric process converts them in an optical fluorescent signal.  This 
signal can then be detected by the PMT and translated into an electrical signal.  Prior to 
the 1990’s, a commonly used scintillator was Bismuth Germanium Oxide (BGO) due to 
its good characteristics for 511 keV gamma-photon detection.  However, the superior 
count rate capability of lutetium oxyorthosilicate (LSO) has made it the scintillator of 
choice today, despite it featuring a decay of natural 176Lu itself. 
A square array of PMTs is attached to the back of the scintillator crystal.  A PMT 
is a vacuum tube, containing a photocathode, a series of dynodes, and an anode.  It 
allows weak light signals in the ultraviolet to near-infrared range to be detected.  When 
gamma-photons strike the scintillator crystal, all PMTs simultaneously detect the same 
flash of light to varying degrees, depending on their position relative to the individual 
event. The photons emitted from the scintillator strike the photocathode in each of the 
PMTs. When this happens the photocathode ejects electrons.  These electrons are 
multiplied millions of times through series of dynodes, allowing for the detection of even 
individual photons.  The arrangement of PMTs of the detector block in combination with 
accompanying circuitry, allows the system to locate what region of the scintillator 
absorbed the photon by detecting the relative amount of light sensed by the array. 
Based on the knowledge that PET radiotracer annihilations simultaneously emit 
two 511 keV photons in opposite directions, a PET scanner uses information from 
gamma-photons detected in near time-coincidence (using a typical temporal window of 6 
to 12 nanoseconds, and as low as 400 picoseconds for ‘time-of-flight’ capable systems40-
42).  If two detected events are registered as coincident, it is then possible to locate the 
annihilation event from which they originated as lying somewhere along a line joining 
the detected events. This line joining detected events is called a line-of-response (LoR).  
When the LoR correctly represents the paths of the annihilation photons, and thus the 
location of the annihilation event, the detected event is called a ‘true coincidence’ event 
(see Figure 1-12).  A 3D image of radiotracer distribution inside a patient can be 
calculated by measuring hundreds of thousands of detected events along different LoRs. 
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Figure 1-12: A 'true' coincidence event.  The line-of-response connecting the two 
coincidence events correctly reflects the location of the positron annihilation.13 
1.3.1 Quantitative Errors and Correction Techniques 
Quantitative measurement of radiotracer distribution in PET imaging is not trivial, as the 
physical processes of photon scatter and attenuation, must be factored into the calculation 
of spatial location and even the detection of events.  Additionally, the PET scanner has 
limitations in terms of photon count rate capabilities, and determining the location of 
detected events.  Each of these processes and limitations must be accounted for during 
image reconstruction, and in the following sections I will discuss how this is 
accomplished through the use of detector normalization, and corrections for dead time, 
random and scattered coincidences, as well as the attenuation gamma-photons. 
1.3.1.1 Normalization 
The efficiency of gamma-photon conversion into an electrical signal can vary from one 
block detector to another.  Small variations in scintillator crystal dimensions and 
differences in the quality of their optical coupling to the array of PMTs can cause these 
differences in efficiency, leading to variations in resolution and sensitivity throughout the 
FoV.  We can account for these variations by recording the number of counts detected by 
each detector pair after uniform exposure to a radionuclide source, and then applying 
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corrections to the projection data before proceeding to tomographic reconstruction.  This 
process is called normalization.   
Although all detector pairs are exposed to the same number of coincidence gamma-
photons, some will record more counts than others.  This can be accounted for by 
calculating the normalization factor (𝑁𝐹) for each detector pair (𝑎, 𝑏) using, 
 𝑁𝐹(𝑎,𝑏) =  𝑛𝐶𝑜𝑢𝑛𝑡(𝑎,𝑏) 𝐴𝑣𝑔𝐶𝑜𝑢𝑛𝑡⁄ , (3) 
where 𝑛𝐶𝑜𝑢𝑛𝑡(𝑎,𝑏) is the number of coincidence events counted by detector pair 𝑎 and 𝑏, 
and 𝐴𝑣𝑔𝐶𝑜𝑢𝑛𝑡 is the average counts for all detector pairs. The number of counts for 
each detector pair can be corrected by entering the normalization factor for each detector 
pair into the following equation,  
 𝐶𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑(𝑎,𝑏) =  𝑝𝐶𝑜𝑢𝑛𝑡(𝑎,𝑏) 𝑁𝐹(𝑎,𝑏)⁄ , (4) 
where 𝑝𝐶𝑜𝑢𝑛𝑡(𝑎,𝑏) is the number of detected counts in a patient scan.  
1.3.1.2 Dead Time 
During the detection of a gamma-photon, a signal pulse with finite time duration is 
produced in the detector.  When additional signal pulses occur prior to the first pulse 
finishing, those additional pulses are lost and a single distorted pulse is formed.  These 
lost valid events are called dead time losses and to prevent the underestimation of 
radioactivity concentration, corrections for dead time must be applied.  The majority of 
PET systems fit paralyzable or non-paralyzable dead time models to empirical dead time 
models constructed from measurements taken with various radioactivity concentrations 
in a range of object sizes and using different energy thresholds.  Dead time corrections 
can be applied globally for the whole system, or to individual pairs of detector modules. 
1.3.1.3 Random Coincidence 
When two distinct annihilation events occur simultaneously, and a single gamma-photon 
from each event is detected in coincidence, an erroneous LoR is created.  This type of 
coincidence event is called a random coincidence (see Figure 1-13).  Random 
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coincidence events degrade image contrast by adding a uniform background of counts 
across the PET FoV.  These additional background counts skew the relationship between 
the quantitation of localized activity in a PET image and the actual concentration of 
radiotracer in the corresponding region of the patient.   
 
Figure 1-13: A 'random' coincidence event, resulting in a line-of-response (red 
dotted line) for a non-existent annihilation, while failing to account for the two 
actual annihilations.  This false line-of-response contributes incorrect positional 
information to the image data. 
A commonly used method to correct for random coincidences involves an 
additional acquisition window with a time delay.  If a true coincidence event is recorded 
as two detection events within a discrete window of time, then the rate of random 
coincidences can be estimated by temporally shifting the window of time for one of the 
detectors in a pair.  This effectively pairs gamma-photons from two distinct annihilation 
events, preventing any true coincidence events from being detected.  The estimated rate 
of random coincidences can then be removed from the raw PET data that is collected. 
Given that the above random coincidence rate measurement is a sample and not 
the actual random coincidence count occurring within the true coincidence window, 
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subtracting this estimated value will introduce statistical noise. The amount of 
uncertainty remaining after this correction can be calculated by, 
 𝜎(𝑇𝑟𝑢𝑒𝑠+𝑆𝑐𝑎𝑡𝑡𝑒𝑟) =  √(𝑇𝑟𝑢𝑒𝑠 + 𝑆𝑐𝑎𝑡𝑡𝑒𝑟) + (2 × 𝑅𝑎𝑛𝑑𝑜𝑚𝑠) (5) 
where 𝑇𝑟𝑢𝑒𝑠, 𝑆𝑐𝑎𝑡𝑡𝑒𝑟, and 𝑅𝑎𝑛𝑑𝑜𝑚𝑠 represent the true coincidence count, the number 
of scattered coincidence events, and the number of random coincidence events, 
respectively. 
1.3.1.4 Scattered Coincidence 
A scattered coincidence occurs when one or both gamma-photons are redirected from 
their original trajectories by Compton scattering, yet are still detected in coincidence 
(Figure 1-14).  Scattered coincidences compromise spatial resolution and quantitative 
accuracy, in a manner similar to that of random coincidences, and contribute to 
background counts that are dense towards the center of the FoV.  
The topic of scattered radiation in quantitative PET imaging has been a long time 
focus in many publications.43-50 As such, a great deal of research has been invested in the 
development of compensation strategies.  Among them, the most commonly 
implemented today is the iterative model-based scatter correction.51 This correction 
method begins by taking a measurement of the distribution of densities within the 
imaging subject from a preliminary reconstruction of the projection data containing both 
true and scattered coincidences.  The PET system’s computer then uses the preliminary 
reconstruction, the density measurements, and a photon propagation model to simulate 
the scatter detected, producing an estimate of the scatter distribution.  This estimate can 
then be iteratively subtracted from the projection data. 
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Figure 1-14: A 'scattered' coincidence event.  The scattered gamma-photon provides 
incorrect positional information for the positron annihilation event. 
1.3.1.5 Photon Attenuation 
Photon attenuation is the gradual loss of photon flux through a medium.  In PET 
reconstructions that do not account for this type of loss, there often appears to be a 
substantial loss of activity in the central portion of the imaging subject.  Other times the 
effects of attenuation can be subtler and appear as more localized reductions in 
radiotracer activity (see Figure 1-15).  Both outcomes are a crucial source of error, which 
negatively affect the diagnostic accuracy of the scan. 
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Figure 1-15: A comparison of two reconstructions of the same PET data.  A) Image 
reconstruction without correction for photon attenuation from patient tissues, B) 
Image Reconstruction with CT-based attenuation correction. 
Much like a scattered coincidence, Compton scatter is largely responsible for the 
process of photon attenuation.  But unlike a scattered coincidence, one or both of the 
photons are lost as they get scattered away from all detector blocks.  Current methods of 
attenuation correction in PET use an estimation of electron density distribution 
throughout the imaging subject to make corrections during the reconstruction process.  
The spatial distribution of electron densities is used to calculate a mapping of linear 
attenuation coefficients (μ) for 511 keV gamma-photons within the PET FoV.  This is 
commonly called a μ-map.  The accuracy of a μ-map is dependent on the quality of the 
density measurements of the imaging subject within the PET FoV, and the accuracy of 
the gamma-photon propagation models used. 
Various techniques to estimate patient tissue densities for attenuation correction have 
been proposed.  Broadly speaking, these can be grouped into three categories: non-
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transmission techniques, transmission techniques, and more recently, MRI-based 
strategies. 
Non-transmission techniques involve the analysis of radiotracer distribution in 
PET projection data to derive a μ-map.  First, PET projection data is used to create a 
simple geometric boundary around the activity distribution.  Then, a uniform attenuation 
coefficient is contained within this boundary,52,53 which can be created manually or 
through various automated processes using scattered projection data, unscattered 
projection data,54,55 or both.56 Although easily implemented, these techniques often suffer 
from poor contour fits, and fail to reflect the true heterogeneous distribution of densities 
within a patient.57  
Photon transmission data can provide direct measurements of densities within an 
imaging subject.  This can be achieved with an external radionuclide source, or X-ray 
CT.  Both X-ray CT and most radionuclides transmit photons at energies other than 511 
keV.  As such, data from these scans must be scaled for attenuation correction of PET 
photons.  Changes in the dominant photon interactions in different materials complicate 
the conversion from transmission energy data to PET μ-map.  For example, Compton 
scatter is the dominant interaction for 511keV photons in soft-tissues, but in bone 
photoelectric interactions dominate at that energy.  To further complicate the conversion, 
x-ray CT transmits a polyenergetic spectrum of photons, usually in the range of 40-140 
keV.  Fortunately, previous work on this problem has resulted in bilinear mapping 
functions to make these corrections possible and have been shown to work well for both 
single and polyenergetic transmission scans.58-60  
MRI-based strategies for attenuation estimation can be divided into three 
categories: mapping, atlas-based, and segmentation.  Approaches that use mapping 
attempt to convert MRI voxels to linear attenuation coefficients via some mathematical 
function. Despite its potential, the lack of signal from lung and bone tissues in 
conventional MRI pulse sequences, limit our ability to distinguish one from the other.  
An atlas-based approach uses previously acquired data, such as an x-ray CT, to create a 
model or an atlas of the spatial distribution of tissue densities.  This atlas can then be 
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registered to a patient specific MRI, which may be acquired at the same time as the PET, 
to create a patient specific μ-map.  Although this technique can provide distinct density 
information for lung and bone tissues, these values are not patient specific.  Additionally, 
an atlas may not be appropriate to use for patients who significantly deviate from the 
atlas’ sample population.  The third approach, segmentation creates a patient specific μ-
map by dividing the patient’s MR image into the various classifications of tissues.  Each 
tissue class is then assigned a theoretical attenuation value.  Similar to mapping 
approaches, segmentation cannot easily distinguish between bone and lung tissues based 
solely on voxel intensity.  However, the current implementation on a Siemens mMR 
Biograph PET/MRI, which uses a 2-point Dixon sequence to map fat- and water-based 
tissues into a 4-class model (background, lungs, fat, and soft tissue) for whole-body 
scans, provide similar results to those of conventional attenuation correction with low-
dose CT.61,62 More recently, methods to better differentiate air and bone with the use of 
ultrashort echo time sequences (UTE), have achieved a better than 2-4% difference from 
CT-based μ-maps for brain imaging.63,64  
1.4 Hybrid Imaging 
Although PET provides clinicians with the ability to image specific molecular targets 
associated with cancer to help facilitate earlier diagnosis and improve patient 
management, its usefulness is limited without anatomical reference.  The hybridization of 
PET with anatomical modalities like CT and MRI has been an important catalyst to the 
growth in clinical use of PET for oncology imaging.  Hybrid PET/CT and PET/MRI 
offer better coregistration between modalities than images acquired during separate 
sessions, leading to decreased scans times and improved diagnostic accuracy. 
1.4.1 PET/CT 
The late 1990’s saw the introduction of hybrid PET/CT, catalyzing the proliferation of 
PET as a diagnostic tool.  The ability to relate specific molecular information, through 
the distribution of biologically active radiotracers, to detailed anatomical information, via 
x-ray CT, has helped to make PET/CT a powerful tool for cancer detection.  Moreover, 
the specificity of 18F-FDG PET/CT has been shown to help in the identification of non-
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specific benign lesions,65,66 and its sensitivity can aid in the early detection of tumours, 
making early treatment possible.67  
FDG-PET/CT has also been shown to be a useful tool in cancer staging.  It was 
found to be more accurate than CT alone, for staging disease in the mediastinum of lung 
cancer patients.68 Studies have shown FDG-PET/CT to improve the prediction of stage I 
and II disease over PET alone, in patients with non-small cell lung cancer (NSCLC).  
Additionally, hybrid PET/CT allows for better prediction of tumour size, nearby tissue 
involvement (T), and nearby lymph node involvement (N) in patients with lymphoma.69  
Follow-up PET scans may help detect progressive disease or recurrence and 
selectively offering a PET/CT scan to patients without symptoms may allow for an 
effective follow-up treatment.70  
The hybridization of PET and CT has also allowed for much faster, less noisy, 
and higher spatial resolution μ-maps than previously used radionuclide transmission 
scans.  However, the use of x-ray CT results in a higher dose to the patient, due to the 
increased flux of photons.  Compared to a typical radionuclide transmission scan, which 
can impart a dose of 0.20-0.26 mSv,71 an average whole-body CT scan can deliver 
anywhere from 7.22-25.95 mSv, depending on the protocol used and, the patient size.72 A 
standard FDG-PET imaging session can result in a whole body dose of 6.23-10.73 
mSv.72,73 Dose reduction strategies for X-ray CT, including iterative reconstruction 
algorithms, x-ray tubes with variable current, and models of statistical processes of x-ray 
measurements have been investigated by many groups to deal with the issue of patient 
dose.74-79 It is also important to note that acquisition parameters can be adjusted for a 
‘PET attenuation correction only’ CT to achieve doses as low as 0.5-1mSv.80  
1.4.2 PET/MRI 
Combining the molecular information of PET with the excellent soft-tissue contrast of 
MRI represents the merging of two very different but flexible imaging modalities.  
Although CT is excellent for acquiring detailed images of boney anatomy, MRI 
outperforms it in soft-tissue imaging.  A prospective comparison in determining disease 
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extent in CT and MR images of soft-tissue sarcomas showed that 23% of tumours found 
in MRI were missed in CT.81 These findings are consistent with other studies involving 
soft-tissue cancer imaging.82,83 These findings suggest that PET/MRI may be 
advantageous over PET/CT in some oncology screening and perhaps treatment planning 
applications. 
At the beginning of section 1.3, I discussed the role of photomultiplier tubes 
(PMTs) in conventional PET and PET/CT scanners to locate the absorption of gamma-
photons within the scintillator crystal. However, a significant technical hurdle in the 
hybridization of PET with MRI was the PMT’s sensitivity to magnetic fields.  Mu-metal 
is a metallic alloy characterized by its ability to attenuate magnetic fields.  In 
conventional use of PMTs, mu-metal is wrapped around a PMT to shield it from low-
frequency magnetic fields.  Unfortunately, the multi-Tesla fields of MRI systems exceed 
the mu-metal’s shielding ability, rendering PMTs useless.   
Several designs have been proposed, to overcome this incompatibility.  One 
design placed the PMTs and all metallic PET detecting components outside the MRI’s 
magnetic field, and lead scintillation light to the PMTs with fiber-optic cables.84-90 
Although, the magnetic field’s influence on the PMTs was effectively reduced, the 
design degraded performance and reduced the FoV of PET.87 Other designs involving 
special magnets, such as field-cycled magnets91 and split magnet systems92 have also 
been implemented.  However, these systems have limited performance, due to the weaker 
field strengths of these magnet designs.  Some of the more widely commercialized 
designs have forgone the traditional PMT altogether, and replaced them with solid-state 
silicon photo sensors called avalanche photodiodes (APDs)93 or another called silicon 
photomultipliers (SiPMs).94 These compact photo sensors are not sensitive to magnetic 
fields93,94 and are now used in preclinical,87,96-98 and clinical hybrid PET/MRI 
systems.99,100 Although insensitive to magnetic fields, both APDs and SiPMs are 
temperature sensitive and are designed with water cooling systems to maintain a constant 
temperature of 20°C and 18°C respectively. 
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Significant efforts have been invested in optimizing both PET and MRI hardware 
components for compatibility, to minimize interference between modalities in clinical 
systems.  To prevent gradient field linearity of the MRI from being distorted, PET 
detection hardware is made with non-magnetic materials and designed to be gradient 
transparent.  To prevent interference with the MRI’s RF signals, all PET detector 
electronics are shielded from emitting their own RF signals.   
To optimize MRI hardware compatibility with PET, MRI RF coils have been 
designed with specific geometries and materials to optimize their PET photon 
transparency.  Additionally, rigid hardware components that have a fixed position in 
relation to the patient table, such as a head RF coil, a breast coil, or the patient table 
itself, have CT-based μ-maps to provide attenuation correction during PET 
reconstruction.  Given that the PET/MRI can identify the position of the patient table for 
each scan, and these rigid components have a fixed position, relative to the patient table, 
their μ-maps can be registered appropriately and incorporated into the reconstruction 
process.  PET transparency is emphasized for more flexible hardware components, which 
cannot be located in this manner. 
1.5 Imaging for Radiotherapy Planning 
Radiation therapy uses precisely targeted and controlled doses of high-energy ionizing 
radiation to kill cancer cells while attempting to spare normal healthy tissues.  Since the 
late 1970’s, radiotherapy planning techniques use CT image volumes of patient anatomy 
to define target volumes and calculate radiation doses to the tumour and surrounding 
tissues.101 Since then, the incorporation of other imaging modalities such as MRI and 
PET has proven useful in radiotherapy planning. These modalities can provide additional 
information to more precisely define the locations of both tumours and vital organs.102-104 
Soft-tissue contrast in MRI is superior to that of CT.  This allows a clinician to better 
discriminate between a target and the surrounding healthy tissue.105,106 PET allows 
specific molecular characteristic of tissues to be identified, allowing a radiation 
oncologist to prescribe an escalated radiation dose to more aggressively growing 
tumours.107,108 Combining information from multiple modalities can reduce the 
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uncertainty of tumour location, size, and invasiveness, thus potentially improving 
treatment outcomes. 
1.5.1 Motion Management 
The image quality for all three modalities can be compromised in the presence of motion.  
Motion management strategies for CT, MRI, and PET have been studied extensively, and 
many potential solutions have been suggested.   
Although respiratory motion can affect thoracic, abdominal, and pelvic tumour 
sites, it is most prominent and often seen with lung tumours. The challenge of imaging in 
the presence of respiratory motion has brought about various techniques to either 
mitigate or capture this motion. These techniques attempt to provide sufficiently accurate 
images to facilitate patient diagnosis and intervention guidance. In the case of the latter, 
we can look to image-guided radiation therapy (IGRT) as an example of how both clarity 
of the image and motion information are of great importance in the presence of 
respiratory motion.109 As the technology of radiation therapy (RT) delivery systems 
evolve, efforts to capitalize on these improvements by maximizing target dose and 
minimizing collateral dose to critical structures will be accomplished through 
increasingly conformal planning target volumes (PTVs). To make this possible, the pre-
treatment imaging used to create such conformal PTVs must also evolve to incorporate 
the best in tissue contrast, molecular information, and motion characterization. 
Among the modalities used for pre-treatment imaging, three have garnered the 
interest of many working on the problem of respiratory motion in 3 dimensional (3D) 
imaging and motion management; they are X-ray Computed Tomography (CT), 
Magnetic Resonance Imaging (MRI), and the hybridization of both with Positron 
Emission Tomography (PET). 
1.5.1.1 Motion and CT 
The first technique is slow CT, where multiple respiration phases are captured for each 
slice.110-112 This provides a motion averaged image volume, showing the range of tumour 
motion during the acquisition.  One advantage to this approach is the volume distribution 
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used to calculate the dose is similar to that of the motion that would be observed during 
free-breathing treatment.  However, motion averaging in the image and potential 
deviations during treatment from the imaged motion range may increase observer errors 
for both target and normal organ delineations.109  
The second technique is a breath-hold acquisition, performed at both end 
inhalation and end exhalation.113 Although this technique offers significantly reduced 
motion blur caused by free-breathing, the scanning time required for this is often more 
than double. This technique is also dependent on patient compliance.  Otherwise, a gated 
acquisition might be needed, which requires a respiratory monitoring system.  It is 
important to note that gated free-breathing and breath-hold acquisitions do not offer 
identical positioning and this must be taken into account when using for treatment 
delivery planning. 
The last (and most common) of the three techniques is four-dimensional CT (4D-
CT), which can provide detailed temporal information in addition to the 3D spatial 
information that we get from the previously mentioned techniques.114,114 Information 
about tumour range of motion, average tumour position, and tumour proximity to other 
organs during each phase of respiration can be obtained with 4D-CT.116 Although this 
technique provides a promising solution to capturing respiratory motion in lung tumours, 
it is still subject to artefacts from variable breathing patterns, even with the 
implementation of breathing-training.117  
1.5.1.2 Motion and MRI 
As with all of the above-mentioned CT techniques, 4D-CT suffers from poor soft-tissue 
contrast when compared to MRI.  Also, due to imaging dose, CT may not be the ideal 
modality for monitoring disease progression or tumour response through serial imaging. 
MRI however, provides excellent anatomical imaging with superb soft-tissue 
contrast. Also, with no ionizing radiation exposure to the patient during scans, it comes 
as no surprise that it is currently used for screening, staging, and more recently both pre- 
and during-treatment guidance.  Most respiratory motion management strategies for 
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clinical MRI aim to correct for motion artefacts, instead of capturing motion information.  
In a similar manner to the previously mentioned strategies used for CT, respiratory 
motion in MRI can be managed with the use of various breath-hold118-120 or gating 
strategies.121,122 The remaining strategies, which aim to capture respiratory motion, have 
generally been accomplished by one of two methods; using rapid 3D acquisitions over 
time (3D+t),123 or fast 2D acquisitions over time and repeated in adjacent slices in the 
third dimension (2D+t+D).124 For the latter, each 2D image slice needs to be 
retrospectively assigned to the appropriate respiratory state to build each 3D image 
volume.  This is done by using a surrogate for respiratory phase.125-127 However, many of 
these techniques are limited to T1-weighted sequences, which generally have inferior 
tumour-tissue contrast compared to longer TR, T2-weighted and diffusion-weighted 
imaging.123,125-127  
1.5.1.3 Motion and PET 
The availability of radiotracers capable of targeting specific characteristics of cancer, like 
rapid cell proliferation and hypermetabolism, along with great sensitivity to these 
radiotracers in low concentrations, have made PET an important imaging tool in 
oncology.  More importantly, its hybridization with CT has made it possible to accurately 
locate biochemical processes of PET tracers in relation to patient anatomy in CT 
images.128 For example, the use of 18F-fluorodeoxyglucose (FDG) -PET/CT has been 
shown to be more accurate at staging disease, tumour size, nearby tissue invasion (T), 
nodal involvement (N), for patients with non-small cell lung cancer (NSCLC).68 For this 
to be achieved, good spatial correlation between the two modalities must be ensured to 
accurately locate PET activity, and since the CT is used to calculate the attenuation map 
for PET, correlation is also necessary for quantitative accuracy. 
More recently we have seen the hybridization of MRI with PET,99 and since then 
studies have shown it to be as effective as PET/CT at identifying and staging disease, and 
more so in certain applications.129,130 It has also been suggested that PET/MRI be the new 
standard for detecting liver metastases,131 and with new techniques that capitalize on 
PET/MRI’s simultaneity, it could become a standard for motion imaging. 
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However, due to the low photon fluence rate of PET imaging, longer acquisition 
times are required.  Depending on the protocol, these scan times can be on the order of 
minutes to hours.  These longer scan times make PET images more susceptible to motion 
blurring artefacts, particularly in thoracic images where respiratory and cardiac motion is 
difficult to impossible for the patient to control.  Motion blurring in PET for cancer 
diagnosis, staging and intervention planning can lead to quantitative inaccuracies of 
radiotracer concentration estimation, overestimation of lesion volume, and spatial 
mismatches between modalities when hybridized.132 PET events can be linked with a 
timestamp when recorded in a format called list-mode.  These timestamps can be used in 
combination with a respiratory surrogate or a hybrid modality, to sort photon detection 
events into separate 'bins'.  Bins can then be used to include/exclude photon detection 
events in the image reconstruction, to correct respiratory motion blurring through 
techniques called 'respiratory-correlated dynamic PET' or 'gated'/'4D-PET'. 
 Respiratory-correlated dynamic PET requires a 68Ge point source placed on the 
diaphragm of the patient within the FoV, PET data is acquired, and images are 
analysed.133 Those with the point source at a specific position are separated to identify a 
specific phase.  Sinograms can then be reconstructed iteratively from the separated data.  
Although this technique does not require any tracking hardware to monitor patient 
respiratory motion, the computation time required is a disadvantage. 
The more commonly used gated-PET divides photon events from each phase of 
respiration into separate bins.  These bins are independently used to reconstruct static 
images, representing the different phases of respiration.  Although the result is a motion-
free image for each respiratory phase, gated-PET only makes use of a portion of the 
coincidence events, causing noisy images.  Increasing acquisition times or increasing 
radionuclide dose can improve noisy images, but neither of these is desirable.  To reduce 
noise without increasing time or dose, several types of motion correction techniques that 
make use of all coincidence events, have been proposed.  These include simultaneous 
estimation of motion and image reconstruction,134 reconstruction using a time-varying 
system matrix,135-137 event rebinning,138-140 and summing of aligned images.141-143  
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1.6 Gaps in knowledge, challenges, questions, and 
hypothesis 
Since the introduction of clinical hybrid PET-MRI systems, research exploring its 
potential applications has garnered a great deal of interest.  The fusion of PET’s 
molecular information with MRI’s superb soft-tissue contrast provides excellent 
anatomical landmark information for target delineation for radiotherapy planning.  MRI 
acquisitions often require the positioning of RF-coil hardware within the FoV and these 
components are a significant source of photon attenuation in hybrid PET-MRI systems.  
Current MR-hardware attenuation correction methods rely on the conversion of CT scans 
of the MR- hardware to attenuation maps.  However, these CT scans use x-rays in the 
kilovoltage range and are susceptible to various types of artefacts caused by dense 
materials found in the hardware.  Artefacts in these CT images get incorporated into the 
attenuation maps, leading to quantitative inaccuracies in PET data they are meant to 
correct. Additionally, recent developments in radiotherapy technology are allowing for 
more conformal planning to treat moving targets in patients.  As such, imaging protocols 
designed to correct and characterize motion will be more commonly used in planning and 
the quality assurance of these protocols will be needed.  Future applications of hybrid 
PET-MRI in radiotherapy planning will be effected by the following challenges: 
1. The integration of PET imaging for adaptive radiotherapy planning strongly 
depends on the quantitative accuracy of target volumes.  In hybrid PET-MRI this 
requires accurate correction for PET photon attenuation caused by the presence of 
MRI hardware in the PET FoV.  Current kilovoltage CT-based methods of 
constructing MRI hardware μ-maps are prone to various artefacts caused by the 
dense materials in the hardware.  As a result, PET volumes reconstructed with μ-
maps that contain these errors will also contain inaccuracies.  Hence, there is a 
need for a technique capable of producing artefact free images of MRI hardware 
for the purpose of calculating accurate μ-maps for PET. 
2. In the case of lung, liver, and esophageal cancers, motion can be problematic for 
radiotherapy treatment planning images. Before motion correction imaging 
protocols can be incorporated into a radiotherapy planning workflow, quality 
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assurance tests should be available to confirm the protocol’s ability accurately 
mitigate the effects of motion or characterize the motion.  Current methods used 
for quality assurance of CT imaging and radiotherapy to moving targets involve 
the use of programmable motion phantoms, such as the Quasar respiratory motion 
phantom (Modus Medical Devices, London, Canada) and the CIRS Dynamic 
Thorax Phantom (Computerized Imaging Reference Systems, Incorporated, 
Norfolk, USA).  However, these phantoms cannot be run within the static 
magnetic field of an MRI, and are not designed for use with a PET tracer.  
Therefore, there is an unmet need for a simple quality assurance phantom, similar 
to that of the Quasar phantom that is compatible with MRI, PET, and CT, suitable 
for hybrid PET/MRI. 
To address these challenges, I have posed the following research questions: 
1. Can accurate μ-maps be derived from DECT and MVCT images of RF coils, for 
use in quantitative PET-MR imaging? 
2. Can an MR-PET compatible motion phantom be designed to evaluate the 
accuracy and PET sensitivity of respiratory-triggered PET-MRI protocols under 
controlled conditions? 
3. Can tumour respiratory motion be characterized using coregistered dynamic 3D 
MRI and PET volumes? 
Therefore the work within this thesis investigates the following hypotheses: 
1. MVCT can significantly improve the accuracy of mu-maps for RF coils used 
for hybrid PET-MRI. 
2. Verification of moving target accuracy in hybrid PET-MR images requires a 
custom PET and MRI compatible motion phantom. 
3. Multi-phase 4D-PET-MRI can yield more information about tumour motion 
characteristics than single-phase respiratory-triggered PET-MRI. 
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The overarching goal for this research was to further develop PET-MR imaging for 
applications in precision radiotherapy. 
1.7 Thesis Overview 
1.7.1 A Comparison of Megavoltage, Dual-energy, and Single-
energy CT-based µ-maps for a 4 Channel Breast Coil in 
PET/MRI (Chapter 2) 
Two novel CT-based methods of constructing attenuation maps of MRI hardware for 
PET imaging are described and compared with a previously described method by Aklan 
et al (2013).144 Current methods of creating attenuation maps for MRI hardware, such as 
the one described by Aklan, use CT images derived from a single-energy spectrum of 
photons in the kilovoltage range.  This technique is prone to artefacts caused by the 
interaction between highly attenuating components in the hardware and photons in this 
energy range.  The first of our CT-based methods uses a single-energy spectrum of 
photons in the megavoltage range.  Higher energy photons allow for better penetration 
through dense materials resulting in fewer image artefacts.  The second of our methods 
uses a dual-energy spectrum approach to reconstruct virtual monoenergetic image 
volumes.  Monoenergetic images are less susceptible to one of the sources artefact 
caused by the interactions of polyenergetic spectra in the kilovoltage range and highly 
attenuating material.  Improvements in hardware imaging can increase the accuracy of 
corrections needed while they are in the PET field of view.  With PET playing an 
increasingly important role in radiotherapy planning, this work represents a step towards 
improving the utility of hybrid PET/MRI in radiotherapy applications through more 
quantitatively accurate PET in the presence of MRI hardware. 
1.7.2 Accuracy and sensitivity of respiratory-triggered PET-MRI 
evaluated using a multi-modality motion platform (Chapter 3) 
This chapter describes the development and testing of a multi-modality compatible 
tumour respiratory motion phantom for use in the development and quality assurance of 
hybrid PET/MRI or PET/CT imaging protocols.  The phantom was designed to be used 
with an MRI-compatible motion stage developed in previous work, “Design and 
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evaluation of an MRI-compatible linear motion stage,” published in Medical physics vol. 
43 (1) pp. 62-71 (2016) by Tavallaei MA, Johnson PM, Liu J, Drangova M.145 Testing of 
the completed phantom involved measurements and evaluation of currently available 
clinical protocols on a Siemens mMR Biograph, hybrid PET/MRI.  This chapter focuses 
on using the phantom to test a real-time 2D balanced steady-state free precession MR 
sequence to characterize motion and a respiratory-triggered PROPELLER MRI protocol 
combined with gated PET in reproducing moving lesion-compartment geometries and 
tracer quantities.  This work provides a necessary tool for the protocol development in 
chapter 4 and fulfills an unmet need for a PET/MRI/CT-compatible motion phantom that 
can be used for quality assurance of hybrid imaging techniques with motion correction.  
1.7.3 Development and evaluation of an amplitude-based 4D-
PET/MRI protocol to characterize tumour respiratory motion 
(Chapter 4) 
In Chapter 4, an amplitude-based 4D-PET/MRI protocol is described and evaluated in 
the physical phantom model presented in Chapter 3.  One simulated regular and two 
irregular respiratory motion patterns taken from real patient data where used to evaluate 
this protocol.  The irregular respiratory patterns exhibit different combinations of the 
three types of breathing irregularities that may be encountered in a clinical scenario; 
frequency changes, amplitude changes, and baseline shifts.  
1.7.4 Conclusions (Chapter 5) 
The final chapter of this thesis first summarizes the main findings of the previous 
chapters and discusses the experimental and clinical relevance of the results.  This is 
followed with a discussion of possible directions for future research related to these 
findings. Lastly, the final conclusions of this thesis are presented. 
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Chapter 2  
2 A Comparison of Megavoltage, Dual-energy, and 
Single-energy CT-based µ-maps for a 4 Channel Breast 
Coil in PET/MRI 
Women with an increased average breast tissue density as assessed by x-ray 
mammography have been found to also have an increased risk for breast cancer.1-33 This 
emphasizes the need for alternate imaging modalities that are not as susceptible to the 
attenuating effects of dense breast tissue for high-risk patients. PET/MRI combines 
anatomical and functional information within the same scan and could help with early 
detection in high-risk patients by using multispectral higher resolution MRI with higher 
sensitivity unispectral PET. However, the radiofrequency (RF) breast coil used for 
receiving signal during breast imaging with MRI attenuates the 511 keV PET photons. 
To correct for this, a mapping of electron densities (µ-map) of the RF breast coil must be 
created and incorporated into the PET reconstruction process.   This emphasizes the need 
for alternate imaging modalities that are not as susceptible to the attenuating effects of 
dense breast tissue for high-risk patients. PET/MRI combines anatomical and functional 
information within the same scan and could help with early detection in high-risk 
patients by using multispectral higher resolution MRI with higher sensitivity unispectral 
PET. However, the radiofrequency (RF) breast coil used for receiving signal during 
breast imaging with MRI attenuates the 511 keV PET photons. To correct for this, a 
mapping of electron densities (µ-map) of the RF breast coil must be created and 
incorporated into the PET reconstruction process.   
Previous work to correct MR hardware attenuation in PET has been primarily 
based on CT imaging in the 50-100 kV range.4-8 These methods are capable of producing 
high resolution images based on the electron densities of the hardware materials, which 
are then converted into mappings of narrow beam attenuation coefficients (NBACs).  
However, imaging metal components of hardware in the kV range often results in metal 
artifacts.9 These along with under sampling artifacts can compromise the accuracy of the 
resulting µ-map and PET reconstruction. To reduce the appearance of such metal 
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artifacts, some have used lower resolution 68Ge transmission scans as a reference to the 
CT,4 while others have used a threshold of NBACs in the CT-derived µ-map.5,8 In the 
absence of a 68Ge transmission scanner and in the interest of mapping all hardware 
components without artifacts, these methods are not accessible to most users. 
Work has also been done with imaging materials that have high atomic numbers 
using dual-energy CT (DECT) or a cobalt source.  It has been shown that beam-
hardening artifacts, resulting from high-density material attenuating low energy photons 
in a polychromatic x-ray beam, can be reduced by using virtual monochromatic image 
reconstruction from DECT.10-12 It has also been shown that the higher energy photons 
(1.25 MeV) are not susceptible to photoelectric effect but instead fall in the range for 
Compton scattering, providing images that are free from the artifacts produced in the kV 
energy range.13 Further that the megavoltage CT (MVCT) method produces a linear 
relationship between the Hounsfield values of the imaging volumes and the density of 
materials in those volumes.14  
Here, I propose either of two methods by which measurements of MRI hardware 
attenuation can be acquired using a virtual monochromatic image calculated from a 
DECT, or by using a 6 MV linear accelerator that has been detuned for imaging with a 
mean photon energy of 1.0 MV.  Either of these measurements (DECT or MVCT) can be 
converted into a mapping of 511 keV NBACs for use in PET/MRI.  I then investigate the 
performance of these methods against a previously proposed method using single energy 
CT (SECT). 
2.1 Materials and Methods 
2.1.1 Hybrid PET-MRI System 
All imaging was performed on a Biograph mMR whole-body hybrid PET/MRI scanner. 
(Siemens Healthcare, Erlangen, Germany).15 The integrated PET detector assembly is 
located between the RF and gradient coils.  It is made up of 448 detector blocks 
(arranged into 8 rings of 56) 59.4 cm in diameter, 25.8 cm in length, and shares the same 
isocenter as the magnet system.  Each detector block is composed of an 8×8 array of 
lutetium oxyorthosilicate (LSO) crystals fixed to a 3×3 array of water-cooled Avalanche 
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photodiodes (APDs).  The magnet system of the mMR is a 3 Tesla superconducting 
magnet with a 60 cm bore and 199 cm from front cover to back (actual magnet length is 
163 cm).  The whole-body gradient coil system has a maximum strength of 45 mT/m and 
slew rate of 200 T/m/s.  In addition to the integrated RF body coil, there are various other 
RF coils provided with the mMR that have been designed for simultaneous acquisition 
with PET. 
RF coils that do not have a fixed position in relation to the patient table are 
designed to be nearly PET transparent by optimizing geometries and materials.  For RF 
coils that have a rigid construction and are fixed to the patient table, µ-maps are created 
and incorporated into the reconstruction process.  In this work, I evaluate and compare 
three µ-map construction methods for a dedicated MR breast coil (rigid and fixed) during 
simultaneous acquisition of PET and MRI. 
2.1.2 Four-channel RF Breast Coil 
The breast coil used in this study was the MR-BI320-PA (Noras MRI Products GmbH, 
Würzburg, Germany) (Figure 2-1).5 It has a two-channel patient pad coil, on which the 
patient lies prone.  The padding of the pad coil is made of polyethylene foam with a 
polyurethane “skinfoam” coating.  This pad coil lies directly on top of the all fiberglass 
frame, which also contains a two-channel insert plate coil.  The plate coil locks into the 
base of the frame at bed level. The pad coil and plate coil form a high resolution, 4-
channel phased array configuration, allowing the use of integrated parallel acquisition 
technique (iPAT) in the anterior–posterior and left–right directions with an acceleration 
factor of R = 2. The design of the frame has open sides to allow insertion of the breast 
immobilization and biopsy system, as well as simultaneous basic imaging of both breasts 
in all directions.  The spine coil is removed from the patient table and the breast coil is 
held in position on the scanner bed using a polycarbonate fixation plate, which was 
fabricated in-house. 
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Figure 2-1: The MR-BI320-PA four-channel breast coil assembly with 2-channel 
pad coil on top and 2-channel insert plate coil, located in the lower part of the all 
fiberglass frame. 
2.1.3 Breast Phantoms 
To quantitatively and qualitatively evaluate the performance of each hardware µ-map 
construction method, a PET/MR breast phantom was fabricated.  Previous work with the 
MR-BI320-PA four-channel breast coil has shown that it performed well in both an MR-
only breast phantom and breast cancer patient imaging, providing good MR image 
quality.5 In our study, I are primarily interested in evaluating µ-map performances in AC-
PET reconstructions; therefore our phantom was designed with mainly PET in mind. The 
phantom consists of two tapered cylindrical compartments made of polypropylene.  Each 
compartment of 946 ml can be filled with liquid solutions of MR-phantom doping agents 
and radiotracer to be imaged with both PET and MRI simultaneously.  
A breast phantom fixture was designed and made from polystyrene rigid foam to 
position each breast phantom cylinder within the four-channel breast coil, to provide 
specific and repeatable positioning with minimal PET attenuation: Figure 2-2(A). To 
ensure identical positioning of the breast phantom on the patient table in the absence of 
the breast coil, a polystyrene rigid foam replica of the breast coil frame base and insert 
coil assembly was also designed and fabricated: Figure 2-2(B).  Experimental setup 
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including the breast coil is shown in Figure 2-2(A) and without the breast coil in Figure 
2-2(B) for our control reference. 
 
Figure 2-2: Experimental setups.  (A) Setup for acquisition in the presence of the 
RF breast coil with two breast phantoms positioned within the coil using a 
polystyrene rigid foam fixture made in- house.  (B) Setup for acquisition without the 
breast coil present.  A replica of the breast coil base was made to position the breast 
phantoms identical to their position within the breast coil. 
2.1.4 Attenuation Correction 
In a clinical PET/MR breast scan, PET photons are attenuated by materials along the way 
to detectors. These materials include the various components of MR hardware within the 
field of view (FoV), including the accessory breast coil and patient table, in addition to 
the patient themselves.  To ensure quantitative accuracy of PET images, all attenuating 
materials within the FoV must be accounted for, and corrected.  Currently, MR hardware 
attenuation is corrected with µ-maps created from CT scans, which map the spatial 
distribution of different hardware materials and their respective NBACs.  I evaluated the 
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performance of three CT-based models for MR hardware µ-map construction: (1) SECT, 
(2) DECT, and (3) MVCT.  All CT scans were acquired with the four-channel breast coil, 
including the frame, the pad coil, and the insert coil, as well as the fixation plate present.  
The patient table of each CT scanner was removed from all images by manually cropping 
volumes with 3D Slicer’s Crop Volume module.16 For each of the three breast coil µ-
maps, PET reconstructions were performed offline using Siemens’ PET reconstruction 
software, e7 tools (Siemens Molecular Imaging, Knoxville, USA).  Attenuation 
correction of the PET/MR patient table is automatically applied during the PET 
reconstruction process, using a CT-based µ-map that is provided with the PET/MR 
system. 
2.1.4.1 SECT-based Model 
The SECT scan was performed on a Philips Brilliance CT Big Bore (Philips Healthcare, 
Cleveland, OH). The system used a peak tube voltage of 120 kVp, a tube current of 379 
mA, and a calculated effective energy of 76 keV.  The reconstructed image volume had 
voxel dimensions of 1.2×1.2×1.0 mm3, and a matrix size of 512×512×892.  A 2 mm 
Gaussian filter was applied to the CT image volume and a bilinear function was used to 
convert Hounsfield unit (HU) values into attenuation coefficients for 511 keV photons, 
using code written in house with Matlab v9.0 (The MathWorks, MA USA).17 The 
bilinear function is based on NBACs for H2O and cortical bone, calculated from tables 
published by Hubbell and Seltzer.18 The values used for the above-mentioned conversion 
for an effective energy of 76 keV were 0.1868 cm-1 and 0.4468 cm-1 for H2O and cortical 
bone, respectively.  To match the spatial resolution required for the hardware µ-map, our 
SECT-based µ-map was resampled using 3D Slicer’s Resample Image (BRAINS) 
module.16 To reduce the effects of image artifacts in the µ-map due to high atomic 
number components, such as metal in the electronics, a threshold was applied to the 
NBACs between 0.02 and 0.12 cm-1 for 511 keV photons, as proposed by Aklan et al 
2013.5,7,8  
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2.1.4.2 DECT-based Model 
A DECT scan of the breast coil assembly was acquired on a GE Healthcare Discovery 
CT750 HD scanner (GE Healthcare, Waukesha, WI, USA).11 This system uses a single 
tube that is capable of rapidly switching between two tube potentials (80 kVp and 140 
kVp) every 0.2 milliseconds. A simulated monochromatic image volume at 100 keV was 
calculated from the two sets of SECT images to reduce beam-hardening artifact from the 
metal components of the RF coil.  This was accomplished using a method described by 
So et al 2011.11 The simulated monochromatic image volume had voxel dimensions of 
0.98×0.98×5.0 mm3, and a matrix size of 512×512×360. A 2 mm Gaussian filter was 
applied to the µ-map and, similarly to the method used for the SECT-based µ-map, a 
bilinear function was used to convert HU values into attenuation coefficients for 511 keV 
photons, using code written in house with Matlab v9.0 (The MathWorks, MA USA).17 
The values used for this conversion at 100 keV were 0.1707 cm-1 and 0.3562 cm-1 for 
H2O and cortical bone, respectively.  The DECT-based µ-map was resampled to match 
the spatial resolution required for the hardware µ-map, using 3D Slicer’s Resample 
Image (BRAINS) module,16 and the same NBACs threshold as used for the SECT maps 
was applied (between 0.02 and 0.12 cm-1) to reduce the effects of noise and any 
remaining metal artifacts in the image.5,7,8 
2.1.4.3 MVCT-based Model 
MVCT images were acquired on a TomoTherapy Hi-Art linear accelerator 
(TomoTherapy, Madison, WI, USA).19 The Hi-Art has a 6 MV linear accelerator 
mounted on a CT type ring gantry, which also allows the acquisition of MVCT images 
using the same radiation source while detuned to an average energy of 1.0 MV.  Before 
acquiring MVCT images of the breast coil, a calibration scan was performed to calculate 
the relative electron density to HU value curve for the MVCT beam energies used on the 
Hi-Art. A cylindrical solid water phantom with holes for placing plugs for CT density 
tests called a ‘cheese’ phantom (Gammex RMI, Middelton, WI, USA) was used. Three 
plugs were made of three different materials with high atomic numbers, similar to 
components found in the breast coil. The materials used were aluminum (6061 T6), 
copper (C110), and stainless steel (304).  The plugs were placed in the cheese phantom 
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along with several other plugs of varying densities (Figure 2-3) and MVCT images were 
taken of the phantom.  These images were then used to plot a linear relationship between 
the relative electron density of the materials and their corresponding Hounsfield values. 
The dimensions of the breast coil were greater than the High-Art’s FoV of 40 cm, 
therefore two separate images had to be taken.  One image was taken with the breast coil 
positioned slightly to the right of the patient table and then another with it positioned 
slightly to the left.  Each of the reconstructed image volumes had voxel dimensions of 
0.763×0.763×4.0 mm3, and a matrix size of 512×512×245.  Translation of the images 
into their appropriate overlapping positions was performed manually using 3D Slicer.16 
Fusion of the images was performed in Matlab with in-house code.  The resulting image 
volume was then translated into the required position relative to the bed with 3D Slicer’s 
registration module.16 The relative electron densities of the breast coil materials were 
calculated from the HU values obtained in the MV image volume and the newly 
calibrated relative electron density curve calculated from the calibration scan. NBACs 
were then calculated for 511 keV photons from the relative electron density map, to 
create the MVCT-based µ-map. A 2 mm Gaussian filter was applied to the µ-map and it 
was resampled to match the spatial resolution required for the hardware µ-map. 
 
Figure 2-3: Cylindrical solid water ‘cheese’ phantom (Gammex RMI, Middleton, 
WI, USA) with eight tissue-simulating plugs and three plugs made in-house: A) 
aluminum, B) copper, and C) stainless steel. 
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2.1.5 PET Acquisition 
Two separate PET datasets were acquired to evaluate and compare the performance of 
the three different CT-based µ-maps: 1) With the breast coil, 2) Without the breast coil 
(used as reference standard).  PET data from the second acquisition was corrected for 
physical decay. 
A fixture made of polystyrene rigid foam was used in the first PET acquisition to 
achieve identical positioning of the breast phantoms to the second set of acquisitions with 
the breast coil in place. For both acquisitions, each breast phantom contained distilled 
water with approximately 27 kBq/L of 18F.  The breast phantoms were then placed in the 
same table location (with and without breast coil) and positioned at the isocenter of the 
PET FoV where emission data was collected for 40 minutes. 
All PET reconstructions were performed using the Ordinary-Poisson Ordered 
Subsets Expectation Maximization (3D-OP-OSEM) algorithm20 (3 iterations, 21 subsets, 
and 2 mm Gaussian filter). The resulting image volumes had: matrix size = 172×172, 
slices = 127, and voxel size = 4.0×4.0×2.0 mm3. The manufacturer’s reconstruction 
software provided scatter correction for all PET image reconstructions. 
Attenuation of the breast coil and breast phantoms was corrected with each of the 
three CT-based µ-maps in separate reconstructions (Table 2-1). Five different 
reconstruction scenarios were carried out: 1) the acquisition in the presence of the breast 
coil, but without correcting for the breast coil’s attenuation (PET_NAC). This 
reconstruction was used to measure the effects of the coil’s attenuation. Using the same 
emission data from this first acquisition, the breast coil attenuation was corrected using 
the: 2) SECT-based µ-map (BC_ACSECT) for the reconstruction PET_SECT, 3) DECT-
based µ-map (BC_ACDECT) for PET_DECT, and 4) MVCT-based µ-map (BC_ACMVCT) 
for PET_MVCT.  The second acquisition was in the absence of the breast coil where no 
µ-map was required for the breast coil (N/A). This reconstruction was used as our 
reference standard (PET_REF). 
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After each reconstruction, µ-maps for the patient table, breast coil, and phantom were 
visually examined for alignment (Figure 2-4). 
Table 2-1: Summary of reconstruction scenarios carried out to evaluate both the 
attenuation of the breast coil and the three proposed CT-based methods to correct 
for MR hardware attenuation. 
MR Hardware Setup Attenuation Correction PET Reconstruction 
With Breast Coil NAC PET_NAC 
 BC_ACSECT PET_SECT 
 BC_ACDECT PET_DECT 
 BC_ACMVCT PET_MVCT 
No Breast Coil N/A (reference standard) PET_REF 
 
Figure 2-4: Axial, coronal, and sagittal views of a µ-map composed of 
manufacturer’s table µ-map, the SECT-based breast coil µ-map, and the phantom 
µ-map fused into a single volume. 
Total true counts for both the acquisitions with the breast coil and without the 
breast coil were used to determine the total counts lost in the presence of the breast coil. 
Relative differences of activity between the reference standard acquisition 
without the breast coil and each of the four reconstructions with the breast coil present 
were calculated. These images were used to evaluate the effect of the breast coil’s 
presence on PET signal and the accuracy of each AC method.  Five cylindrical regions of 
interest (ROIs), shown in Figure 2-5(A)-(B) were assigned within the breast phantom for 
each of the five reconstructions (PET_REF, PET_NAC, PET_SECT, PET_DECT, and 
PET_MVCT). The mean and standard deviation of all ROIs across the included 
67 
 
transverse slices (slice 49 to 75) were calculated for each reconstruction and reported in 
terms of their percent difference from the reference standard. 
 
Figure 2-5: ROIs used to calculate relative percent difference images.  (A) Axial 
view of breast phantom with ROIs.  (B) Coronal view of breast phantom showing 
the range of transverse slices (49 – 75) used for plotting each ROI. 
2.2 Results 
Total true counts without the breast coil present were 3.33E+09 and in the presence of 
the breast coil was 3.002E+09. This made for a total loss of 9.9% from the breast coil 
attenuating PET photons.  
Evidence of photon attenuation from the presence of the breast coil can be seen in 
a comparison of the PET_REF and PET_NAC reconstructions (Figure 2-6(A) and (B)), 
particularly in the lower-right region of the axial view and the left side of the sagittal 
view. This can also be observed in the relative difference image (Figure 2-7(A)).  The 
reconstruction corrected with the BC_ACSECT µ-map (Figure 2-6(C)) shows an 
improvement of the lost signal in the lower-right region of the axial view but also shows 
some overcorrection in the left sides of the coronal and sagittal views.  The 
reconstruction performed with the DECT-based AC (Figure 2-6(D)) shows less of the 
overcorrection observed in the Figure 2-6(C).  Better still, the MVCT-based AC 
reconstruction (Figure 2-6(E)) bares the closest resemblance to the reference standard 
(Figure 2-6(A)), with most of the areas of lost activity recovered and regions of 
overcorrection reduced. 
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The relative difference images confirm the observations made in each of the PET 
reconstructions, with overall improvement in the amount of activity recovered with each 
of the three different µ-maps (Figure 2-7(B)-(D)) over the image without coil AC (Figure 
2-7(A)).  Common amongst all three AC reconstructions (Figure 2-6(C)-(E)) is 
overcorrection in the lower region of the breast phantom.  This coincides with the area 
that showed the greatest decrease in activity (Figure 2-6(B)), due to its proximity to the 
breast coil’s most attenuating components.   
This is also seen in plot for the relative percent difference of ROIs between 
PET_REF and PET_NAC (Figure 2-8(C)).  ROI 3 is positioned in the lower portion of 
the breast phantom (Figure 2-8(A)), and the attenuating effects of the breast coil are 
greater there than in the ROIs positioned higher in the phantom (ROI 1, ROI 2, ROI 4, 
ROI 5).  The overcorrection of this lower region can also be seen in each of the plots for 
the three CT-based reconstructions (Figure 2-8(D)-(F)).  The ROI analysis also showed 
mean percent differences from the reference standard to be approximately -1% to -9% 
without correcting for the attenuation caused by the presence of the breast coil ( 
 
 
 
Table 2-2).  Correcting for this attenuation showed approximate values of -2% to 7%, -
3% to 6%, and -3% to 5% difference from the reference standard for the SECT-based, 
DECT-based, and MVCT-based corrections, respectively ( 
 
 
 
Table 2-2). 
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Figure 2-6: Breast phantom PET images in axial, coronal, and sagittal views for 
each reconstruction scenario.  (A) Breast phantom only (PET_REF).  (B) Breast 
phantom and breast coil without coil AC (PET_NAC).  (C) Breast phantom with 
breast coil and SECT-based coil AC (PET_SECT). (D) Breast phantom with breast 
coil and DECT-based coil AC (PET_DECT).  (E) Breast phantom with breast coil 
and MVCT-based coil AC. 
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Figure 2-7: Relative difference of PET images measured in percent.  (A) Relative 
difference between the reference standard (PET_REF) and with the breast coil but 
without coil AC (PET_NAC).  (B) Relative difference between PET_REF and with 
breast coil and SECT-based AC.  (C) Relative difference between PET_REF and 
with breast coil and DECT-based AC (PET_DECT).  (D) Relative difference 
between PET_REF and with breast coil and MVCT-based AC (PET_MVCT). 
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Figure 2-8: ROI comparison of relative percent difference images.  Plots show the 
relative percent difference between mean ROI values for PET_REF vs. (A) 
PET_NAC, (B) PET_SECT, (C) PET_DECT, and (D) PET_MVCT. 
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Table 2-2: Mean and standard deviation of the percent activity difference calculated 
between the reference standard (PET_REF) and each of the four AC scenarios 
(PET_NAC, PET_SECT, PET_DECT, and PET_MVCT) performed on PET data 
collected in the presence of the breast coil. 
 PET_NAC  PET_SECT  PET_DECT  PET_MVCT 
Mean SD  Mean SD  Mean SD  Mean SD 
ROI 1 -0.85 1.54  -2.10 1.01  -2.62 0.74  -3.41 0.87 
ROI 2 -3.76 2.05  1.81 1.37  0.68 1.09  -0.19 1.16 
ROI 3 -8.71 1.49  7.02 1.49  6.20 1.15  5.04 1.16 
ROI 4 -3.44 2.32  1.95 1.19  1.18 0.94  0.25 0.98 
ROI 5 -5.55 2.46  -0.04 1.29  -1.93 0.95  -2.52 0.96 
2.3 Discussion 
Both PET and MRI have been used extensively in oncology imaging due to the 
advantages of excellent specificity and sensitivity of PET and improved soft-tissue 
contrast of MRI over x-ray images.  For this reason, hybrid PET/MRI shows great 
promise as a tool for early cancer detection in high-risk patients.  Ensuring compatibility 
of MRI hardware, such as RF coils, with PET continues to be an active area of research 
and in this study I describe two CT-based µ-map construction methods and compare their 
performance with a method described in Aklan et al. (2013).5 It was shown that both the 
DECT and MVCT-based µ-maps of the RF breast coil, when used during PET 
reconstruction, were capable of correcting for the breast coil’s attenuation of PET 
photons.  Both the DECT and MVCT-based methods performed comparably to the 
SECT-based method in recovering activity in the breast phantom, while showing less 
overcorrection in the more attenuated regions.  This is clear when comparing the plotted 
values of ROI 3 for each of the percent difference plots in Figure 2-8.  Similar 
differences between ROI regions are observed in Aklan et al. (2013).5 Overcorrection or 
undercorrection is due to the combination of scatter correction and attenuation correction.  
Theoretically, if all scattered and random events are corrected for, then one should be 
able to reconstruct a (relative) quantitatively accurate reconstruction using narrow-beam 
attenuation coefficients.  
73 
 
However, if the projection data still contains counts that are not “trues”, using 
narrow-beam attenuation coefficients will over-correct, resulting in a reconstruction that 
has an increased count density in the middle compared with the perimeter.  Conversely, if 
the provided scatter correction removes too many counts, the result is a photopenic 
effect. 
The improvements observed in the DECT and MVCT-based correction methods 
were due to the reduction of metal artefacts in the CT images from which the µ-maps 
were derived, resulting in more accurate attenuation coefficients in the highly attenuation 
materials (Figure 2-9(A)-(F)).  Although the virtual monochromatic images reconstructed 
from the DECT images showed a noticeable improvement over the SECT images, metal 
artifacts remained.  This is due to projection truncation and/or photon starvation at lower 
energies of the two spectra.  As a result, a similar set of thresholds were applied to the 
511 keV NBACs of the DECT-based µ-map as were applied to the SECT-based µ-map 
in an attempt to reduce the effects of any remaining artefacts.  However, the MVCT 
images did not contain any visible metal artefacts leading to an artefact-free µ-map.  No 
thresholds were applied to the MVCT-based µ-map, given the significant reduction of 
visible artefacts. 
Previous work by Aklan et al. (2013) on CT-based µ-map construction for MR 
hardware AC has shown that pre-acquired SECT-based µ-maps of the same breast coil 
used in this study allowed for AC of RF coil hardware components in PET data.  Their 
phantom data shows an 11% loss in total true counts in the presence of the coil.  ROI 
analysis showed the variation of mean values for relative difference images to go from 
4%-16% to -4%-4%, for non-AC and AC images, respectively.5 The feasibility of their 
approach to RF coil AC is also demonstrated with the PET/MR data of two breast cancer 
patients.5 This SECT-based technique to RF coil AC has been similarly applied to other 
MR hardware components.5,8,21,22 In our study, a breast phantom different from the one in 
Aklan et al. (2013) was used.  As a result some of the PET activity values for our 
replication of this technique were different.  However, using the same PET data for each 
of the AC techniques in this study limits the introduction of other variables that might 
contribute to the difference seen between techniques.  Our results suggest that DECT and 
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MVCT-based µ-maps can provide improved quantitative accuracy in the more attenuated 
regions of PET data, which may otherwise see overcorrection with a SECT-based µ-map.  
This is due to metal artefact being less prominent in these two imaging techniques. 
While the phantom used does not exhibit the same geometries as a patient, it was 
still able to provide a controlled model with which the various AC techniques could be 
evaluated and compared.  Future work with a more biologically accurate phantom and/or 
patient data should be done to validate our DECT-based and MVCT-based RF coil AC 
techniques further. 
 
Figure 2-9: A comparison of high-density components in three different µ-maps.  
The SECT-based µ-map is shown in (A) Axial, (B) Sagittal, and (C) Coronal views.  
Dotted lines represent intersecting planes shown in frames outlined in matching 
color.  A close-up of high density components in the breast coil (green rectangle in 
frame A) are shown in the (D) SECT-based µ-map, (E) the DECT-based µ-map, and 
(F) the MVCT-based µ-map. 
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2.4 Conclusions 
The proposed DECT and MVCT-based µ-map construction techniques have been 
evaluated and compared with a previously used SECT-based technique in a breast 
phantom model.  Both techniques provide a feasible approach to MR hardware AC for 
PET, while showing less overcorrection in the more highly attenuated regions of the 
phantom, than what was seen with the PET images corrected with the SECT-based µ-
map.  The DECT and MVCT images, from which the µ-maps were calculated, showed 
less metal artifact than the SECT images.  Furthermore, the µ-map derived from the 
MVCT did not require any additional processing, whereas both the SECT and DECT-
based µ-maps required the application of thresholds to mitigate the effects of metal 
artifacts.  The application of our DECT-based and MVCT-based RF coil AC techniques 
for other system hardware components could also be of value in trying to improve the 
integration of MR imaging with quantitatively accurate PET. 
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Chapter 3  
3 Accuracy and Sensitivity of Respiratory-Triggered PET-
MRI Evaluated Using a Multi-modality Motion Platform 
The challenge of imaging in the presence of respiratory motion has necessitated various 
techniques to either mitigate the effects of1-3 or measure motion.4-6 These techniques are 
designed to facilitate patient diagnosis7,8 and in some cases intervention guidance.4-6 In 
the case of the latter, image-guided radiation therapy (IGRT) is an example of how both 
image accuracy and motion information are of great importance in the presence of 
respiratory motion.9 As radiation therapy (RT) delivery systems evolve technologically, 
efforts to capitalize on these improvements by maximizing target dose and minimizing 
collateral dose to critical structures will be accomplished through increased planning 
target volume (PTV) conformality.  To make this possible, the pre-treatment imaging 
must also evolve to incorporate optimal tissue contrast, molecular information, and 
motion characterization. 
Although commonly used for RT planning, x-ray computed tomography (CT) 
suffers from poor soft-tissue contrast when compared to magnetic resonance imaging 
(MRI).  MRI on the other hand provides superb soft-tissue contrast, but unlike CT, is 
unable to measure electron density directly; tissue electron density is required to 
calculate RT plans and for attenuation correction in molecular imaging (e.g. positron 
emission tomography (PET)). 
Increased radiation dose to biologically active subregions of a tumour volume can 
be used to improve treatment outcomes.  Positron Emission Tomography (PET) imaging 
of tumours can help provide the necessary target localization,10 when combined with the 
appropriate anatomical reference image.  Hybrid PET-MRI systems are becoming 
clinically available and allow molecular information from PET and anatomical 
information from MRI to be acquired in a single session.11-13 Additionally, the true 
simultaneity of this hybrid system allows for better spatial correlation of the modalities 
than hybrid serial PET/CT systems.14  
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Currently, most imaging protocols require the patient to hold their breath during 
acquisition when respiratory motion is a concern.  However, breath holds engage 
different muscles than free breathing, potentially resulting in a different tumour position 
than what would occur during a free breathing treatment delivery.  If we are to use the 
additional information that can be provided by MRI and PET for the purposes of RT 
planning, patients will need to be free breathing during image acquisition. 
MR imaging protocols to visualize lung tumours commonly include a free 
breathing acquisition, using a steady state gradient echo sequence (e.g. fast imaging with 
balanced steady state free precession (TrueFISP)) to visualize the extent of tumour 
motion, followed by the acquisition of a respiratory-triggered T2-weighted turbo spin 
echo (TSE) sequence (e.g. the periodically rotated overlapping parallel lines with 
enhanced reconstruction (PROPELLER) technique)15 obtained at end exhalation to 
characterize tumour size and location.  On a hybrid PET-MRI scanner, metabolic 
information about lung lesions can be acquired simultaneously with 18F-FDG PET.  
While these methods are commercially available, their accuracy – specifically related to 
the ability to minimize motion artefact – is not routinely verified, likely since no quality 
assurance phantom that verifies the accuracy of respiratory-triggered PET/MRI currently 
exists. The aim of this study is to evaluate the accuracy and PET sensitivity of 
respiratory-triggered PET-MRI protocols under controlled conditions.  The effects of 
motion magnitude on accuracy and sensitivity are evaluated for a range of motion 
amplitudes and tumour sizes using a programmable PET-MR-CT compatible respiratory 
motion phantom with known tumour geometries and PET-tracer activity concentrations. 
This evaluation can serve as a platform for developing routine quality assurance 
procedures. 
3.1 Materials and Methods 
3.1.1 Phantom Design 
A phantom was created to represent an average human torso with air cavities 
representing the lungs. The phantom (shown in Figure 3-1) is made up of five 
compartments, all of which are made of acrylic.  The main torso compartment is a closed 
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cylinder 285 mm long with an internal oval cross-section measuring 292 mm wide by 
240.5 mm high. Contained within the torso compartment are three smaller cylinders 
running the full length of the torso – two 89 mm wide by 125.5 mm high compartments 
represent the lungs and a 32.3 mm wide by 23.6 mm high compartment can 
accommodate spine mimicking material.  A 77 mm diameter opening in the superior end 
of the torso compartment allows it to be filled and emptied; a 10.7 mm diameter hole in 
the same end is used to fill/empty the spinal compartment.  The two lung compartments 
are open at the inferior end of the torso to allow a lesion-mimicking compartments to 
move freely inside while attached to the MRI compatible motion stage.16 Lesions were 
simulated with acrylic spheres affixed to acrylic stems. While various lesion sizes and 
shapes can be fabricated, I evaluated four “lesions” – 28 mm, 22 mm, 17 mm, and 10 
mm internal diameters, similar to existing NEMA image quality phantoms.17 The 
phantom design enables the non-lung cavities to be filled with liquids with varying x-
ray/gamma attenuation, MRI properties, and radioactive PET tracers. 
The phantom is designed for use in combination with the MRI compatible motion 
stage (section 3.1.2).  The stem of each lesion compartment is attached to the motion 
stage with polystyrene extensions thereby allowing the lesion compartments to reach into 
the lung compartment of the torso phantom. 
3.1.2 Motion Stage 
An MRI compatible motion stage (MR_1A_XRV2, Vital Biomedical Technologies, 
London, Canada) was used to provide superior-inferior (S/I) motion mimicking a 
respiratory profile.  The motion stage, which has been described in detail by Tavallaei et 
al (2016), is fabricated of non-magnetic materials and comprises a 95-mm long carriage 
driven along a precisely machined lead screw (50 mm range) by an ultrasonic motor 
(USR60-NM, Fukoku-Shinsei). The motor is controlled by a custom-designed embedded 
system,18 enabling motion to fixed positions as well as continuous dynamic motion, e.g. 
simulating respiration. The stage is capable of reaching fixed positions with an accuracy 
of 0.1 mm with a normalized RMSE below 3% and has been demonstrated to have a 
negligible effect on the magnetic field. 
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3.1.3 Experimental Setup 
To enable evaluation of simultaneous PET and MRI, the compartments of the torso 
phantom and lesion compartments were filled with aqueous solutions that mimic a 
typically injected dose for total body studies and their resulting background and 
metabolically active lesion uptakes.  Specifically, the torso compartment was filled with 
4.27 kBqmL-1 of aqueous 18F solution and each lesion compartment was filled with 17 
kBqmL-1 of 18F solution; the activity levels were selected in accordance with section 7 of 
the NEMA NU2-2007 protocol describing a method to fill an image quality phantom.17 
To reduce the T1 relaxation time of the aqueous solution, 0.03 gL-1 of MnCl2·4H2O was 
added,19 along with 4 gL-1 of NaCl to reduce dielectric-effect artefacts. 
The filled torso phantom was placed at the isocentre of a 3T PET-MRI system 
(Biograph mMR, Siemens Medical Solutions, Erlangen, Germany).  A radiofrequency 
body coil was used to transmit and two six-element flexible Body Matrix coils and 
matching elements of the built-in spine-array coil were used as the receiving coil 
elements.  To enable respiratory triggering/gating of the MRI/PET acquisitions, a 
respiratory bellows was attached to a foam sponge mounted in line with the carriage of 
the motion stage – compression of the sponge as the carriage moves mimics the in vivo 
situation. 
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Figure 3-1: Perspective (a), side (b), and top (c) views of the experimental setup.  
The respiratory bellows and a foam block were attached adjacent the motion stage 
carriage to provide a trigger for the MRI scans.  In the configuration shown four 
lesion compartments were imaged simultaneously as they underwent S/I motion.  
All materials are MRI compatible. 
3.1.3.1 Motion Profiles 
The motion stage was programmed to undergo simulated respiratory motion profiles with 
a period of 3.4 seconds, representing a breathing rate of ~18 breaths per minute.  The 
profiles were calculated from a modified sine wave, where one third of the period was 
suspended. (i.e. for a sine of amplitude 1.0 cm, the peak-to-peak excursion was 1.5 cm, 
with a simulated end exhalation position of -0.5 cm for a duration of 1.13 s).  They were 
defined by: 
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where the position 𝑦 at time 𝑡 is a function of the set amplitude 𝐴 and period 𝑇.  Two 
motion profiles – with amplitudes of 1 and 2 cm (peak-to-peak extent of 1.5 and 3 cm, 
respectively) were evaluated (Figure 3-2). To determine the effect of motion, the lesion 
compartments were also scanned while static. 
 
Figure 3-2: Simulated breathing waveforms for 1.5 cm peak-to-peak motion and 3.0 cm 
peak-to-peak motion. 
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3.1.4 Imaging 
3.1.4.1 MR Imaging 
MR images were first acquired for use in attenuation correction of the PET images; maps 
were acquired with the phantom static and in a simulated breath-hold position to match 
the motion profile respiratory-trigger positions. Specifically, a 2-compartment-mode 
Magnetic Resonance Attenuation Correction (MRAC) map designed for phantoms, was 
used to correct for the water component of the phantom.20 This map was derived from a 
T1-weighted two-point Dixon 3D volumetric interpolated breath-hold examination 
(VIBE) sequence.21 It was acquired with the following parameters: repetition time (TR) = 
4.13 ms, echo times (TE) = 1.23 and 2.46 ms, integrated Parallel Acquisition Technique 
(iPAT) – GeneRalized Autocalibrating Partially Parallel Acquisitions (GRAPPA) R 
factor = 2, number of averages (NA) = 1, flip angle (FA) = 10°, matrix size = 192 × 126, 
slices = 128, voxel size = 2.6 × 2.6 × 3.12 mm3, and acquisition time (TA) = 0:21 min. 
Two pulse sequences, commonly used for RT-diagnosis and planning22-24 were 
evaluated.  First, the respiratory-triggered T2-weighted turbo spin echo sequence 
(BLADE) was used to acquire images of the static and moving tumour phantom. 
Respiratory triggering was provided by the bellows, which was affixed to the motion 
stage. The TR value was set automatically according to the period of the respiratory 
cycle (3406 ms) and trigger threshold was set to 20% of tidal volume above the baseline 
during the exhale position.  Image volumes of the torso phantom were acquired in a 
coronal plane containing all four lesion compartments with the following parameters: TE 
= 105 ms, GRAPPA with R = 2, NA = 1, FA = 128°, echo train length = 30, matrix = 
256 × 256, number of blades = 24, slices = 5, voxel size = 1.3 × 1.3 × 6.0 mm3, 
bandwidth (BW) = 781 Hz/pixel, TA = 0:20/0:32 min. Respiratory-triggered images 
were acquired while the phantom was static and while the lesion compartments were 
moving with motion extent of 1.5 (RT_1.5) and 3 cm (RT_3.0). 
Dynamic images of the moving lesion compartments were also acquired in the 
coronal orientation using the real-time balanced steady-state free precession sequence 
(TrueFISP).25 The scan parameters were: TR/TE = 117.11/1.04 ms, GRAPPA with R = 
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2, NA = 1, FA = 10°, matrix = 96 × 128, slices = 1, voxel size = 3.1 × 2.5 × 6.0 mm3, 
BW = 1002 Hz/pixel.  A total of 51 images were captured over an acquisition time of 
0:29 min, with a frame rate of ~1.76 frames/s, corresponding to 6 frames in a 3.5 s 
respiratory cycle.  These images were used to evaluate the ability to visualize tumour 
motion using the commonly employed TrueFISP approach. 
3.1.4.2 PET Imaging 
List-mode PET data were acquired at a single bed position for 10 minutes.  Count rates 
and total number of counts for the three acquisitions were: static – 19,545 
cps/11,727,255; 1.5 cm motion – 15,354 cps/9,212,460; and 3 cm motion – 15,530 
cps/9,318,175.  While the MRI acquisition times varied for different motion profiles and 
pulse sequences, a fixed acquisition time was used for the PET scans in order to ensure 
the observed differences were a reflection of motion characteristics and not scan 
duration.  PET data were binned according to respiration phase, to match the respiratory-
triggered MR acquisition, then reconstructed using the ordinary Poisson ordered subsets 
expectation maximization (3D-OP-OSEM) algorithm26 (3 iterations, 21 subsets, and 2 
mm Gaussian filter).  Attenuation correction of PET data acquired without phantom 
motion was performed with the static MRAC map.  Attenuation correction of gated PET 
data was performed with MRAC maps in a simulated breath-hold position to match the 
respiratory-trigger positions.  The resulting image volumes had: matrix size = 256 × 256, 
slices = 127, and voxel size = 1.4 × 1.4 × 2.0 mm3.  All acquisitions and phantom motion 
magnitudes are summarized in Table 3-1. 
Table 3-1: Summary of imaging and motion magnitudes evaluated 
Phantom Motion 
(S/I) 
MRI 
Sequence 
List-mode PET 
Duration 
     Static MRAC (2-comp.) 
 
(10 min) 
T2 BLADE-TSE (resp. 
trig.) 
 
 
     1.5 cm, 3.0 cm 
 
MRAC (2-comp.) 
 
(10 min) T2 BLADE-TSE (resp. 
trig.) 
 
Real time TrueFISP  
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3.1.5 Data Analysis 
3.1.5.1 MR Image Analysis 
Displacement of sphere centroids in coronal real-time TrueFISP images were calculated 
and compared with expected values calculated from equation 1.  A binary mask of each 
real-time image was created by assigning voxels with values less than 25% of the 
maximum to zero and all others to one.  Each centroid coordinate was calculated 
according to the following: 
 
𝑐𝑎 =  ∑ 𝑤𝑖𝑐𝑖
𝑛
𝑖=1 ∑ 𝑤𝑖
𝑛
𝑖=1⁄ , 
(2) 
where 𝑐𝑎 is the calculated x, y, or z-coordinate for the centroid; 𝑤𝑖 represents the voxel 
intensity of the 𝑖-th of 𝑛 voxels in the VOI, and 𝑐𝑖 is the x, y, or z-coordinate of the 𝑖-th 
voxel.  Actual and expected displacement values were plotted over time and Pearson 
correlation coefficients were calculated for each motion profile. 
Lesion compartment dimensions were measured manually, using digital callipers 
in 3D Slicer,27 from each BLADE-TSE image.  Measurements were made in the 
direction of motion and orthogonal to the direction of motion (left/right).  These 
measurements were then compared against the known dimensions of the spheres as a 
measure of geometric accuracy of the images constructed from the respiratory-triggered 
BLADE-TSE technique. 
3.1.5.2 PET Image Analysis 
Lesion compartment volumes in PET images were segmented using the method of Erdi 
et al.  In this method, the upper threshold value was set to the maximum voxel value 
within the volume of interest (VOI) and the lower threshold value was set according to a 
calculation based on the source-to-background ratio and the expected lesion volume.28 
Mean voxel value and standard deviation, maximum voxel values, and volumetric 
measurements were calculated with the ‘Label Statistics’ module in 3D Slicer.27  
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Contrast-to-noise ratios (CNR) were calculated using the segmented VOI 
described above. A spherical VOI, identical in size to each lesion compartment VOI, was 
placed within the main torso compartment of the phantom to provide a background (BG) 
measurement. CNR was calculated as follows: 
 
CNR = (?̅?𝑉𝑂𝐼  − ?̅?𝐵𝐺) 𝜎𝐵𝐺⁄   , 
(3) 
3.1.5.3 PET-MRI Alignment Analysis 
Lastly, alignment of sphere compartments between each modality was evaluated. This 
was achieved through visual inspection of independent and fused coronal images of the 
PET, respiratory-triggered BLADE-TSE images. 
3.2 Results 
PET-MRI images were acquired successfully using the developed MRI-compatible 
respiratory motion phantom.  Centroid displacement over time calculated from real-time 
TrueFISP images shows excellent correlation with the expected displacement values 
(Figure 3-3).  Lesion compartment size shows very little effect on these measurements, 
with Pearson correlation coefficients being 0.998 and 0.994 for 28 and 10 mm diameter 
spheres during 1.5 cm of motion and 0.999 and 0.997 for 28 and 10mm diameter spheres 
during 3.0 cm of motion. 
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Figure 3-3: Comparison of expected and measured centroid displacements for 28 
and 10 mm diameter lesion compartment during a) 1.5 cm peak-to-peak motion; 
and b) 3.0 cm peak-to-peak motion in real-time TrueFISP MR images. 
3.2.1 Motion-induced MRI Errors 
Measurements of lesion compartments taken orthogonal to the direction of motion or 
left/right (L/R) and in the direction of motion (S/I) are presented in Table 3-2. 
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Table 3-2: Sphere diameter measurements in respiratory-triggered 
BLADE-TSE images. Measurements were taken in the direction of motion 
(S/I) and orthogonal to direction of motion (L/R) in static images and in 
images acquired during 1.5 cm and 3.0 cm of motion. 
Sphere Diameter 
(mm) 
Motion Extent 
(cm) 
L/R S/I 
28 
Static 28.8 28.8 
1.5 28.8 31.3 
3.0 28.8 33.9 
22 
Static 22.6 22.6 
1.5 22.5 26.3 
3.0 22.5 27.5 
17 
Static 17.5 17.5 
1.5 17.5 20.0 
3.0 17.5 21.3 
10 
Static 10.0 10.1 
1.5 10.0 11.2 
3.0 10.0 12.5 
3.2.2 Motion-induced PET Errors 
Figure 3-4 compares the mean voxel intensity with standard deviations, maximum voxel 
intensity, contrast-to-noise ratio, and volumetric measurements of each segmented lesion 
sphere in PET volumes under both static and triggered conditions.  Both of the 
respiratory-triggered acquisitions should ideally be similar to the reference standard 
acquisition (static).  The RT_1.5 and RT_3.0 acquisitions show lower mean voxel values 
compared to the static acquisition, with mean values being 6.3%-32.3% and 19.2%-
30.4% lower for 1.5 and 3.0 cm of motion respectively.  Maximum values are 2.9%-
13.77% and 19.8%-34.9% lower for 1.5 and 3.0 cm of motion respectively. Contrast-to-
noise values are also lower in both RT_1.5 and RT_3.0 compared to static, with RT_1.5 
being lower by 0.1%-3.4% and RT_3.0 by 22.1%-36.2%.  An increase in volumetric 
measurements of lesion-compartments in the respiratory-triggered acquisitions can be 
seen when compared to the static acquisition.  Volumetric increases are between 4.6 and 
14.1% for the three largest lesion-compartments and 60.7% for the 10 mm lesion-
compartment in the RT_1.5 image.  However, in terms of difference from the known 
volumes, volumes for the three largest lesion-compartments are within 2% for static, 
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12% for RT_1.5, and 18% for RT_3.0.  The 10 mm lesion-compartment measurement is 
within 11% of the known volume in the static image and 123% for RT_1.5.  An 
appropriate volume could not be measured for the 10 mm lesion-compartment in the 
RT_3.0 image due to severe smearing of the activity.  
 
Figure 3-4: (a) Mean voxel intensity of each sphere diameter in PET images during 
static, 1.5 cm, and 3.0 cm (S/I) motion. Error bars represent the standard deviations 
over voxels in VOI. (b) Maximum voxel intensity within in each sphere during each 
of the three cases.  (c) Contrast-to-Noise ratios for each of sphere and motion 
magnitudes.  (d) Segmented volumes for each sphere diameter and motion. 
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3.2.3 PET-MRI Alignment Errors 
Coronal images of PET, MRI, and fused volumes for each motion magnitude are shown 
in Figure 3-5.  Upon visual inspection of the PET images for (a) static, (d) RT_1.5, and 
(g) RT_3.0 motion magnitudes; there is a noticeable amount of additional noise in both 
gated PET images when compared to the static acquisition, which is particularly 
noticeable around the edges of the lesion-compartments.  This is expected, given the 
large number of counts outside of the gating windows not included in the reconstructions. 
The RT_3.0 PET image contains residual motion of the spheres, resulting in the 
appearance of the spheres in (g) being slightly elongated in comparison to the static 
image in (a). Respiratory-triggered BLADE-TSE acquisitions performed well at 
correcting for motion during both the (e) RT_1.5 and (h) RT_3.0 acquisitions, with only 
slight residual motion in the form of ghosting being noticeable on the inferior side of the 
sphere in the RT_3.0.  All three fused image volumes, (c) static, (f) RT_1.5, and (i) 
RT_3.0 show good alignment between modalities. 
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Figure 3-5: Coronal images of (a) PET, (b) MRI, and (c) fused PET-MR of the 
phantom without motion (static) are shown above.  Similarly, coronal images taken 
from a gated PET with respiratory-triggered BLADE-TSE MRI acquisition during 
simulated respiratory motion of the lesion compartments with a magnitude of 1.5 
cm in the S/I direction are shown in (d) and (e) respectively, and for 3.0 cm of S/I 
motion are shown in (g) and (h). Fused image of (d) and (e) is shown in (f), and 
fusion of (g) and (h) can be seen (i). 
3.3 Discussion 
Centroid measurements of lesion compartments in the real-time TrueFISP images show 
excellent correlation with the expected motion profile values.  The accuracy of the 
calculated motion profiles suggest dynamic MR protocols like the one used in this study 
may prove useful in probability distribution function (PDF) based radiotherapy treatment 
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planning.  Previous work done with a similar protocol, using a 10 frame/second over 5 
minute acquisition time, found that increasing frame rate improves accuracy but has less 
of an effect on reproducibility of the PDF.29  
The evaluated respiratory-triggered MRI technique worked well for correcting the 
motion of our multi-modality respiratory motion torso phantom and showed little 
geometric distortion of the moving lesion-compartments in terms of deviation from 
known diameters in both the direction of motion and orthogonally.  Given a 20% trigger 
threshold, the maximum expected motion artefact included in the images is 3 mm for the 
1.5 cm motion profile and 6 mm for the 3.0 cm motion profile.  Measurement increases 
in the direction of motion are between 1.2 and 3.8 mm for 1.5 cm of motion and 2.5 to 
5.1 mm for 3.0 cm of motion. After accounting for partial volume effect (PVE) from 
image sampling, these are within the maximum expected motion artefact values.  The 
gated PET technique was also effective at reducing the effects of motion in the phantom, 
although smearing of PET activity due to motion captured within the gating window 
resulted in reduced mean and maximum voxel values for segmented lesion-compartment 
volumes.  Also, differences in measured mean and maximum values between the 
different sized lesion-compartments are likely the result of PVE.  It has been shown that 
PVE is strongly dependant on volume size such that smaller volumes show greater 
underestimation of activity.30 Lower calculated CNR values are a result of the lower 
mean values for all lesion compartments and similarly the different CNR values between 
different sized lesion-compartments are the result of PVE on mean values.  Volumetric 
measurement increases are likely due to residual smearing of PET activity during gating 
window as well, however the segmentation technique failed to define an appropriate 
volume in the RT_3.0 PET image for the 10 mm lesion-compartment due to severe 
smearing of activity.   
The breath-hold MRAC acquisitions resulted in the expected µ-maps and were 
used for correction of PET images for this study.  Although it would be ideal to correct 
the PET with a gated MRAC, the only currently available MR-based attenuation 
correction technique does not have motion correction capability.  On the other hand, 
performing MRAC images in the presence of motion causes phase encoding artefacts in 
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the anterior-posterior and in the S/I direction. The process of converting the MR image to 
an attenuation map incorporated these artefacts into the map, resulting in an 
overcorrection of attenuation during the PET reconstruction.  Although these results were 
not included, the PET images corrected with MRAC images acquired during phantom 
motion (as opposed to the ‘simulated breath-hold’ MRACs used in this study) also 
possessed unwarranted artefacts that resulted in artificially elevated CNR for the larger 
motion profile acquisitions, and artificially elevated mean SUVs. This suggests that 
motion correction strategies are required for accurate MRAC acquisition, especially 
when a patient is unable to hold his or her breath. 
Recently, Fürst et al evaluated different motion-correction strategies for an 
integrated PET-MRI system, wherein they acquired the patient respiratory signal through 
five different methods to retrospectively gate data.31 From the 14 patient dataset, which 
included lesions in the breast, liver, and pancreas, with additional lungs, lymph node, 
esophagus, and small intestine lesions, it was found that respiratory traces acquired 
through PET data, MR-derived signals, or external sensor (including respiratory 
bellows), were all comparable. The use of bellows in our experimental setup was 
effective at extracting the phantom motion profiles and appeared to sufficiently replicate 
a clinical scenario. Respiratory gating has also been found to provide accurate 
compensation for imaging liver lesions during free-breathing, in a six patient study using 
PET-MRI.32 Evaluating the performance of similar techniques in a repeatable model, 
such as an imaging phantom, brings additional value in terms of known motion profiles, 
geometries, and tracer or doping quantities. 
Standard protocols and parameters were chosen to evaluate the feasibility of 
using hybrid PET-MRI for lung radiotherapy applications, as it currently exists. Several 
techniques have been proposed to correct for motion in PET-MRI that include 
respiration-phase appropriate MRAC maps and show more promise for applications in 
radiotherapy planning including motion management,33-35 but all use the standard breath-
hold Dixon sequence attenuation correction. Some patients may find breath-hold 
protocols challenging and any mismatches between the target respiration-phase in PET 
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and the acquired MRAC will remain uncorrected after the motion correction technique 
has been applied. 
While our phantom does not fully replicate the complexity of anatomy or 
respiratory motion in patients with lung cancer, it does provide a controlled model that 
can provide user defined motion profiles with known geometries, contrasts, and activity 
levels and provides a means for developing routine quality assurance of current clinical 
PET/MR protocols that account for respiratory motion. The phantom designed for this 
study could also be extended to other purposes such as future protocol development in 
hybrid modalities including PET, MRI, and CT.  Although the MRAC acquired in this 
study does not account for the acrylic components of the phantom, all scans were 
acquired under this same condition.  The PET signal lost through the attenuating 
properties of the phantom materials did not appear to hinder the phantom’s ability to 
demonstrate the desired scanning scenarios, nor their effects on the evaluated protocols. 
3.4 Conclusions 
Hybrid PET-MRI offers the potential for superb soft-tissue contrast with relevant 
molecular information for radiotherapy planning in thoracic cases that require motion 
management. Both the respiratory triggered MRI and gated PET acquisitions evaluated in 
this study performed well under the prescribed conditions.  The simultaneous acquisition 
of both the triggered MRI and trigger-based gated PET allows for excellent co-
registration.  However, the current breath-hold protocol used for acquiring and 
calculating MR-based MRAC maps may still pose a challenge for non-compliant 
patients. In addition, the phantom developed for this study provided a good model for 
evaluating the respiratory-triggered PET-MRI protocols (BLADE-TSE and gated PET) 
and real-time TrueFISP imaging with the given respiratory motion profiles. 
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Chapter 4   
4 Description and evaluation of an amplitude-based 4D-
PET/MRI protocol to characterize tumour respiratory 
motion 
Positron emission tomography (PET) has been established as an effective tool to aid in 
cancer diagnosis,1,2 staging,3-8 and determining treatment response.9-11 In combination 
with an anatomical modality like x-ray computed tomography (CT), PET has also proven 
to be useful for radiotherapy treatment (RT) planning.  The combined anatomical and 
molecular information has not only been used to delineate whole target volumes,8,12-17 
but also used to aid in  radiation dose escalation to glucose avid subregions of tumour 
volumes to help improve treatment outcomes.18  
However, the application of 3D PET in thoracic RT planning can be problematic, 
as it often suffers from motion averaging due to respiration.  Motion averaging prevents 
accurate radiotracer activity measurements and obscures the target volume.19 Dynamic 
PET techniques, which correlate subsets of 3D PET data to a particular respiration phase 
or amplitude, offer possible solutions to motion-artefact prone anatomy and have been 
demonstrated with hybrid PET/CT.19,20 However, PET/CT data sets are acquired 
sequentially, with CT scans taking only seconds and PET requiring several minutes to 
acquire a sufficient number of detected coincidence events.  The binning of 3D PET into 
respiratory-correlated data subsets can greatly reduce motion averaging,21,22 but each 
individual data subset alone suffers from diminished photon statistics, decreasing signal-
to-noise. Also, PET subsets may not match the respiratory amplitude/phase of the CT 
acquired in the same imaging session.  As patient attenuation correction (AC) of PET is 
based on a CT image acquired during the same imaging session, the quantitative 
accuracy of PET may suffer as a result of mismatched respiratory amplitude/phase 
between modalities.23 Four-dimensional (4D) CT offers a potential solution to the need 
for a matching anatomical image and AC for each PET subset.  However, the sequential 
nature of these scans still leaves them susceptible to mismatches due to patient shifting 
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between acquiring each modality and possible differences between modalities in 
respiratory positions for each data bin.24  
One major advantage of hybrid PET/MRI is the simultaneous acquisition of both 
modalities.  Previous work on the topic of 4D-PET with MRI have used dynamic sets of 
MRI and/or PET data for the purpose of motion correction while maintaining or 
improving on quantitative accuracy of PET.25-30 But currently, there are no clinical 
implementations of a dynamic 4D-PET/MRI protocol to characterize tumour respiratory 
motion for the purposes of radiotherapy treatment planning. 
In the following, I describe a 4D-PET/MRI protocol using MR sequences and 
PET acquisition methods that are currently available clinically on hybrid PET/MRI 
systems.  This technique is validated using a programmable PET/MRI/CT compatible 
tumour respiratory motion phantom. 
4.1 Material and Methods 
4.1.1 Motion Phantom Study 
A tumour respiratory motion phantom assembly was designed to allow for quality 
assurance measurements of motion correction protocols in PET, MRI, CT or any 
combination of these modalities simultaneously.  The main torso compartment is made of 
acrylic plastic and has an elliptical cross-section to simulate the shape and volume of a 
human torso.  There are two cylindrical openings that extend through the length of the 
torso compartment to simulate lungs.  The torso phantom is hollow and can be filled with 
11.7 L of MR signal-producing fluid (0.03 gL-1 of MnCl2·4H2O and 4 gL
-1 of NaCl) and 
PET radiotracer.  Additionally, there are four acrylic spheres with different internal 
diameters of 10, 17, 22, and 28mm that can also be filled with doped water and PET 
radiotracer. These hollow spheres attach to an MR-compatible linear motion stage 
(MR_1A_XRV2, Vital Biomedical Technologies, London, Canada) via an extension 
holder made of polystyrene solid foam.  The motion stage can be programmed to move 
the spheres in any user define motion pattern and the extension holder allows the acrylic 
spheres to move freely within the lung compartments of the torso phantom (See Figure 
4-1). The motion stage is fabricated of non-magnetic materials and has a 95-mm long 
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carriage with a 50 mm range.  An ultrasonic motor (USR60-NM, Fukoku-Shinsei) drives 
the stage’s motion and can be user defined.  A more detailed description of the motion 
stage can be found in Tavallaei et al (2016).31  
 
Figure 4-1: Side (a), and top (b) views of the experimental setup.  The respiratory 
bellows and a foam block were attached adjacent the motion stage carriage to 
provide a trigger for the MRI scans.  In the configuration shown four lesion 
compartments were imaged simultaneously as they underwent S/I motion.  All 
materials are MRI compatible. 
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In this study, the spheres were each filled with 17 kBq of 18F per mL of MR fluid 
to simulate glucose-avid lung tumours, while the torso compartment was filled with 4.27 
kBq of 18F per mL of MR fluid to simulate normal background uptake in healthy tissues.  
This provided a target-to-background ratio of 3.98. Three PET/MRI acquisitions of the 
phantom were acquired, each with a different motion profile.  Data files from real patient 
breathing traces, captured with a Real-Time Position Management suite (Varian Medical 
Systems, Palo Alto, USA) during CT simulation, were retrospectively used to program 
two of the motion profiles for the motion stage.  Each was scaled to have a maximum 
distance of 17.26 mm between the minimum and maximum amplitude throughout the 
breathing trace.  The first patient trace (RMP-Pat1) had an average respiratory cycle time 
of 3.97 seconds and the second trace (RMP-Pat2) had an average respiratory cycle time 
of 2.34 seconds, and each motion profile demonstrated a different combination of 
respiration irregularities that may be encountered in the clinic.  The third motion profile 
(RMP-Sim) was a simulated breathing trace consisting of a 30 mm peak-to-peak 
sinusoidal motion pattern with a dwell at the bottom third of the profile and a period of 
3.5 seconds (see Figure 4-2). The motion stage was placed on a 9° incline to produce 
motion in both the super-inferior (S-I) and anterior-posterior (A-P) directions. 
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Figure 4-2: Respiratory motion profiles for A) RMP-Pat1, B) RMP-Pat2, and C) 
RMP-Sim. 
Both MRI and PET datasets were acquired and post-processed as described 
above.  Since the motion profile of the phantom is known to be accurate to 0.1 mm with 
normalized RMSE < 3%,32 the motion stage data files and derived respiratory phase 
positions were used as the ground-truth for centroid position comparisons. 
4.1.2 Hybrid PET-MR System 
A hybrid PET-MRI scanner (Biograph mMR, Siemens Medical, Erlangen, Germany) 
was used to acquire both 3D and 4D image data.  The PET scanner is made up of 8 rings 
of 56 detector blocks, located in between the radiofrequency and gradient coils.  Each 
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block has an 8 × 8 array of lutetium oxyorthosilicate crystals, attached to a 3 × 3 array of 
avalanche photodiodes APDs), which are water-cooled.  The system contains no septa 
and the transaxial resolution is 4.31 mm and 5.06 mm full-width at half-maximum 
(FWHM) at 10 mm and 100 mm radius from isocenter, respectively.  The axial resolution 
is 4.28 mm and 6.41 mm FWHM at 10 mm and 100 mm from the isocenter, respectively.  
System sensitivity was measured as 13.2 kcps/MBq along the center of the scanner field 
of view and 10.4 kcps/MBq at a 10 cm radial offset.  These measurements were taken in 
accordance with NEMA standard NU 2-2007 and found to be consistent with a previous 
publication.33 The manufacturer advertises the system to have a coincidence-timing 
window of 5.86 ns and time resolution of 2.93 ns.  The MR component of this system 
contains a ~3.0 T superconducting magnet, with an actively shielded whole-body 
gradient coil with a bore diameter of 60 cm and length of 163 cm.   The gradient coils are 
capable of providing a maximum amplitude of 45 mT/m and a maximum slew rate of 
200 (T/m)/s. 
4.1.3 4D-PET-MRI Technique 
4.1.3.1 MR Imaging 
A two-compartment-model attenuation map (μ-map) was first acquired to correct for 
PET photon attenuation from water content of phantom;34 maps were acquired with the 
phantom in a static position to simulate a breath-hold.  MR-based μ-maps are derived 
from a T1-weighted two-point Dixon 3D volumetric interpolated breath-hold 
examination (VIBE) sequence.35 The following parameters were used for this 
acquisition: repetition time (TR) = 3.6 ms, echo times (TE) = 2.46 ms, integrated Parallel 
Acquisition Technique (iPAT) – GeneRalized Autocalibrating Partially Parallel 
Acquisitions (GRAPPA) R factor = 2, number of averages (NA) = 1, flip angle (FA) = 
10°, matrix size = 192 × 126, slices = 128, voxel size = 2.6 × 2.6 × 3.12 mm3, and 
acquisition time (TA) = 0:21 min.  Dynamic 2D MR images of the phantom with moving 
lesion compartments were acquired in 53 adjacent coronal planes using an ultrafast 
gradient echo pulse sequence (TurboFLASH).36 The scan parameters were: TR/TE = 
242.25/1.12 ms, NA = 1, FA = 10°, matrix = 192 × 192, voxel size = 1.8 × 1.8 × 5.0 
mm3, BW = 1002 Hz/pixel.  Within each of the 53 coronal planes, 50 images were 
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captured over an acquisition time of 11:45 minutes, with a frame rate of ~4.19 frames/s.  
A radiofrequency body coil was used to transmit and two six-element flexible Body 
Matrix coils and matching elements of the built-in spine-array coil were used as the 
receiving coil elements. 
4.1.3.2 PET Imaging 
Dynamic PET data was acquired in list-mode in a single bed position for the duration of 
the MR acquisitions (~ 12 min). Count rates and total number of counts for the three 
acquisitions were: RMP-Pat1 – 417,607 cps/ 300,676,912; RMP-Pat2 – 253,675 cps/ 
182,646,121; and RMP-Sim – 249,462 cps/ 179,612,612. All PET data sets were 
reconstructed offline with ordinary Poisson ordered subsets expectation maximization 
(3D-OP-OSEM) algorithm37 (3 iterations, 21 subsets, and 2 mm Gaussian filter), using 
e7 tools software package (version 2.0) (NYU Langone Medical Center and Siemens 
Healthcare). Decay and scatter correction for all PET image reconstructions were 
performed in e7 tools.  The resulting image volumes had: matrix size = 256 × 256, slices 
= 127, and voxel size = 2.8 × 2.8 × 2.0 mm3. 
4.1.3.3 Image Data Post-Processing 
Respiratory phases were calculated by dividing the distance between the minimum and 
maximum respiratory amplitudes into 5 amplitude positions. Each amplitude position 
was then divided into either inspiration or expiration, based on the slope of the tangent at 
that point in the curve.  This made for a total of 10 respiratory phases.  Data files from 
the motion stage were used as surrogate traces for sorting.  To achieve our 4D-PET-MRI 
technique, all 2D MR images acquired within a coronal slice were retrospectively sorted 
according to amplitude and slope of the point along a surrogate respiratory trace, which 
corresponded to the image acquisition time, using Matlab code written in house.  Phase 
slice bins containing multiple images were averaged.  This was repeated for all slices.  
For cases where an image slice was missing for a particular phase, images from the phase 
with the opposite slope but matching amplitude, or next adjacent phase were used.  The 
result was 10 3D-MRI volumes representing the 10 different phases of respiratory 
motion. 
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Deformation fields were calculated between each of the 10 3D-MRI volumes 
using the General Registration (BRAINS) module in 3D Slicer 4.6.2 with the following 
parameters: B-Spline Grid Size = (15, 15, 5) over the 345.6 × 345.6 × 265 mm3 image 
volume, Maximum Step Length = 0.09, Cost Metric = mean square error (MSE).38 All 
other parameters were set to defaults.  The appropriate subset of deformation fields was 
applied to the MR-based μ-map, which was acquired at a single ‘breath-hold’ position, to 
create μ-maps for the other 9 phases of respiration.   
For each 4D-PET data set, list-mode events were sorted into 10 phases of 
respiration according to the same surrogate and respiratory phases as the 2D-MRI 
sorting, also using Matlab code written in house.  Gated PET data sets included all counts 
within 20% of the respiratory trace above baseline generated by the bellows device.  As 
mentioned above, all binned PET data was corrected for attenuation during image 
reconstruction, using the ‘phase-matched’ MR-based μ-maps.  The full set of 90 
estimated respiratory deformation fields also allowed for warping each PET image 
volume to every combination of respiratory phase.  These deformations were applied and 
counts were summed at each phase to improve the statistics of each image volume.  A 
summary of this process is illustrated in Figure 4-3. 
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Figure 4-3: The workflow for our proposed 4D-PET-MRI technique.  A) 
Construction of 4D-MRI from dynamic 2D images, B) Calculation of 4D-μ-map, 
and C) 4D-PET construction. 
4.1.4 Data analysis 
4.1.4.1 Displacement Accuracy 
Displacement of sphere centroids in all 4D volumes (MRI, PET, μ-maps) were calculated 
and compared with expected values calculated from motion profiles shown in Figure 4-2.  
A binary mask for each sphere in all 4D volumes was created. For MR volumes, VOI 
segmentation was performed based on a thresholding algorithm.39 In PET volumes, 
spheres were segmented using a method describe by Erdi et al., where the upper 
threshold value was set to the maximum voxel value within the spherical volume of 
interest (VOI) and the lower threshold value was set by a calculation based on the 
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source-to-background ratio and the expected lesion volume.40 Each centroid coordinate 
was calculated according to the following: 
 𝑐𝑎 =  ∑ 𝑤𝑖𝑐𝑖
𝑛
𝑖=1
∑ 𝑤𝑖
𝑛
𝑖=1
⁄ , (7) 
where 𝑐𝑎 is the calculated x, y, or z-coordinate for the centroid; 𝑤𝑖 represents the voxel 
intensity of the 𝑖-th of 𝑛 voxels in the VOI, and 𝑐𝑖 is the x, y, or z-coordinate of the 𝑖-th 
voxel.  Actual and expected displacement values for each sphere in all 4D volumes were 
plotted over % respiratory. This was done for each motion profile. 
4.1.4.2 PET Image Analysis 
Mean voxel value and standard deviation, maximum voxel values, and volumetric 
measurements of segmented lesion compartment volumes in PET images were calculated 
with the ‘Label Statistics’ module in 3D Slicer.41 Contrast-to-noise ratios (CNR) were 
calculated using the segmented VOI described above. Spherical VOIs, identical to the 
known size of each lesion compartment, was placed within the main torso compartment 
of the phantom to provide a background (BG) measurement. The following equation was 
used to calculate CNR: 
 
CNR = (?̅?𝑉𝑂𝐼  −  ?̅?𝐵𝐺) 𝜎𝐵𝐺⁄   , 
(8) 
where ?̅? represents the mean intensity of the VOI and 𝜎 is the standard deviation of the 
VOI. 
4.2 Results 
Representative 4D-PET-MR images of RMP-Pat1 are shown in Figure 4-4.  In all three 
cases, both the 4D-MRI and 4D-PET volumes showed good consistency with the motion 
phantom and the derived phase images were adequate enough to characterize the motion 
of the lesion compartments. 
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Figure 4-4: Five frames of 4D-PET/MRI:  Sagittal view of A) amplitude-sorted 4D-
MRI, B) corresponding 4D-PET volumes, and C) MR-based μ-maps of 28 mm 
diameter sphere. 
Figure 4-5 shows the CNR values calculated for the 4D-PET, along with the 
single gate and ungated acquisitions for each of the four spherical lesion compartments.  
The general trend showed all CNR values improve as the size of the sphere increased.  
This was especially the case with the RMP-Sim motion profile, which had a larger peak-
to-peak range. Volumetric measurements of segmented spheres in PET images are shown 
in Figure 4-6. Segmentation method failed for 10 mm sphere in gated and ungated 
reconstructions of RMP-Sim motion, while there was a high level of variability of 10 mm 
sphere volume measurements for all other images. Volume measurements for all 4D 
frames of RMP-Pat1 and RMP-Pat2 showed good agreement with known sphere 
volumes for 17 mm, 22 mm, and 28 mm.  Slight overestimations of volumes for 17 – 28 
mm spheres were seen in the all 4D frames of RMP-Sim motion, due to larger range of 
motion causing residual smearing of activity within each frame, while segmented sphere 
volumes in gated images slightly underestimated and those in ungated images 
overestimated sphere volumes.  Mean voxel values within segmented sphere volumes are 
shown in Figure 4-7. Standard deviation also increased with mean voxel values.  Mean 
voxel values in RMP-Sim images were lower than values for RMP-Pat1 and RMP-Pat2, 
also due to larger range of motion causing residual smearing of activity within each 
frame. 
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Figure 4-5: Contrast-to-noise-ratios of the 10 mm, 17 mm, 22 mm, and D) 28 mm 
diameter spheres for 4D-PET, and single gate PET volumes acquired during RMP-
Pat1, RMP-Pat2, and RMP-Sim motion profiles. 
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Figure 4-6: Volume measurements of segmented spheres in PET reconstructions for 
A) 10 and 17 mm, and B) 22 and 28 mm diameter spheres for 4D, gated, and 
ungated PET acquired during RMP-Pat1, RMP-Pat2, and RMP-Sim motion 
profiles. Horizontal lines indicate known volumes for each sphere. 
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Figure 4-7: Mean voxel intensity of each sphere diameter in PET images RMP-Pat1, 
RMP-Pat2, and RMP-Sim motion profiles. Error bars represent the standard 
deviations between phases of 4D-PET. 
Figure 4-8 shows superior-inferior (S-I) and anterior-posterior (A-P) centroid 
displacement measurements through each 4D phase in PET, MRI, and μ-map volumes 
for the RMP-Pat1 motion profile.  The same measurements for RMP-Pat2, and RMP-Sim 
motion profiles are shown in Figure 4-9 and Figure 4-10 respectively.  In the two patient 
derived motion profiles, RMP-Pat1 has periodic irregularities with an end-inhale 
standard deviation (SD) = 1.93 mm and end-exhale SD = 0.41 mm over the entire 
respiratory trace, while RMP-Pat2 contains a baseline shift with end-inhale S.D. = 1.41 
mm, end-exhale S.D. = 1.02 mm.  Despite these motion irregularities, good agreement 
with expected centroid positions was achieved.  For the regular but larger motion profile, 
RMP-Sim, excellent agreement with expected values was achieved, except in the case of 
the 10 mm sphere in the 0% phase PET image.  A failure of the segmentation technique, 
due to extreme smearing of PET activity, prevented centroid measurement. 
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Figure 4-8: RMP-Pat1 centroid measurements in each frame of 4D PET, MRI, and 
μ-map volumes for the A) 10 mm diameter sphere, B) 17 mm diameter sphere, C) 
22 mm diameter sphere, and D) 28 mm diameter sphere. 
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Figure 4-9: RMP-Pat2 centroid measurements in each frame of 4D PET, MRI, and 
μ-map volumes for A) 10 mm, B) 17 mm, C) 22 mm, and D) 28 mm diameter 
spheres. 
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Figure 4-10: RMP-Sim centroid measurements in each frame of 4D PET, MRI, and 
μ-map volumes for A) 10 mm, B) 17 mm, C) 22 mm, and D) 28 mm diameter 
spheres. 
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Table 4-1: Pearson correlation coefficient values between measured centroid 
displacement positions and their expected position values. 
  28 mm Ø 22 mm Ø 17 mm Ø 10 mm Ø 
  A-P S-I A-P S-I A-P S-I A-P S-I 
RMP-
Pat1 
PET 0.95 0.99 0.96 0.99 0.96 1.00 0.85 0.99 
MRI 0.91 0.99 0.91 0.99 0.98 0.99 0.87 0.99 
μ-map 0.94 0.99 0.96 0.99 0.96 0.99 0.95 0.99 
RMP-
Pat2 
PET 0.91 0.99 0.96 0.99 0.95 0.99 0.87 0.99 
MRI 0.92 0.99 0.95 0.99 0.92 0.99 0.91 0.99 
μ-map 0.90 0.99 0.91 0.99 0.96 0.99 0.90 0.99 
RMP-
Sim 
PET 0.96 1.00 0.94 1.00 0.97 1.00 0.90 1.00 
MRI 0.95 1.00 0.92 1.00 0.96 1.00 0.82 1.00 
μ-map 0.94 0.99 0.96 1.00 0.94 1.00 0.90 1.00 
 
4.3 Discussion 
In this study I reported on a retrospective 4D-PET-MRI technique that uses a respiratory 
surrogate to sort both rapid 2D-MR images over multiple slices and dynamic list-mode 
PET, using an MR sequence and PET acquisition mode that are available on clinical 
systems today.  The preliminary results from this work suggest that this technique can be 
used to image anatomy affected by respiratory motion, and potentially used for target 
delineation in radiotherapy planning of thoracic and/or abdominal lesions.  However, 
further improvements to the image registration technique is desirable to improve the 
ability to characterize lesions smaller than 17 mm in diameter undergoing motion greater 
than 1.7 cm.  A method described by Brehm et al uses a cyclic registration technique for 
motion compensation and found it to outperform spatial registration using demons 
deformable registration algorithm for motion estimation to obtain the deformation fields 
between respiratory phases.42 This strategy may provide the desired improvements.  
Additionally, further optimization of MRI parameters to increase temporal resolution, 
and minimize effects to signal-to-noise ratio and pixel size in-plane could allow more 
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phase volumes to be constructed, improving motion characterization, as well as minimize 
any need to supplement missing phase-slice images with their close approximations. 
Although these preliminary results demonstrate that this technique produces good 
quality images at multiple phases of respiration, this technique needs to be further 
validated with patient data.  Recent work by Fayad et al. describes a technique to 
generate a 4 phase 4D-PET/MR image dataset.  This technique involves the acquisition 
and sorting of PET data into 4 bins corresponding to the 4 predetermined phases of 
respiration. Deformation fields between each non-attenuation corrected PET 
reconstruction are calculated and applied to a single static MR acquisition and MR-based 
μ-map to generate 4D-MRI and 4D-μ-map volumes.28 This study shows a high 
correlation between generated and acquired MR and corresponding μ-maps series, 
reducing the need for longer 4D MR acquisitions.  However, the 4 phases do not 
differentiate between inspiration/exhalation, and thus may not account for lung 
hysteresis.  Additionally, 4 phases may not be sufficient enough to adequately 
characterize motion for radiotherapy planning purposes or correct for larger motion 
profiles. 
It is important to note that the current breath-hold Dixon sequence for attenuation 
correction may prove to be challenging for some patients, and motion during acquisition 
often results in artefacts, which impact PET accuracy.43 As such, the development of a 
free-breathing method may prove beneficial for these cases.  A recently introduced free-
breathing technique has been proposed for cardiac PET-MRI44 and may prove useful in 
other thoracic and abdominal imaging, however this approach is not yet widely available.   
In our PET analysis, extreme smearing of PET activity in the 10 mm diameter 
sphere caused the segmentation technique to fail in the gated and ungated images of the 
RMP-Sim motion.  Although segmentation of the 10 mm sphere was achieved in the 4D 
technique, the instability of CNR and volume values suggest the registration step of our 
method was not able to calculate appropriate deformation fields for this sphere.  This is 
due to its small size in relation to the magnitude of motion.  The CNR values for the 17 
mm sphere in all frames of the 4D PET images were very low, due to inadequate 
119 
 
deformation fields being calculated between phases.  This is all despite improvements in 
mean voxel intensity values seen in segmented VOIs for our 4D technique over the single 
gated PET reconstructions (Figure 4-7). demonstrates a limitation of the registration 
method during larger extents of motion. All other PET measurements suggest our 4D-
PET-MRI technique performed well. 
Centroid measurements of spheres in PET, MR, and μ-maps show excellent correlation 
with the expected motion profile values at each phase (see Figure 4-8 to Figure 4-10).  
However, in all instances the larger deviations from expected centroid positions were 
found in the 10 mm sphere measurements, suggesting a limitation of this technique’s 
ability to characterize motion of smaller tumours (<17 mm diameter).  A motion 
compensated PET/MR technique that uses a novel radial navigated MR pulse sequence to 
construct up to 12 gates is used to calculate deformation fields between gates.26 The 
deformation fields are then applied to both PET and μ-map volumes to create a single 
motion corrected volume.  The simulation study shows the resulting PET image to have a 
10-15% improvement in CNR for 10 mm pulmonary lesions in relation to a single gate 
acquisition.  Although the lack of clinical availability of this pulse sequence is a 
limitation of this technique, it may provide the necessary improvements in temporal 
resolution and contrast to correct for motion of smaller lesions in 4D-PET-MRI.  
4.4 Conclusions 
Our study demonstrates the feasibility of a novel retrospective 4D-PET-MRI technique 
with attenuation correction in a dynamic PET/MR/CT compatible tumour respiratory 
motion phantom.  Our technique has the advantage of using a clinically available pulse 
sequence, eliminating the need for less available more exotic sequences or MR pulse 
sequence programming. 
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Chapter 5  
5 Conclusions and Future Work 
An important goal in radiotherapy planning is to optimize delivered dose to tumours 
while sparing surrounding healthy tissues.  The ability to achieve this goal relies heavily 
on the detail and accuracy of information that can discriminate between cancerous and 
healthy tissues and provide spatial information about the treatment target and 
surrounding tissues.  Hybrid PET-MRI is the marriage of two gold standards in medical 
imaging.  MRI is capable of imaging soft-tissues with superb detail and contrast, and can 
provide information related to perfusion and permeability.  PET on the other hand, in 
combination with an ever-expanding selection of radiotracers, brings complimentary 
information about the distribution of molecular characteristics of tissues.  This thesis 
describes the development of techniques to improve the utility of hybrid PET-MRI for 
radiotherapy planning applications.  In this chapter, I summarize the work and findings 
of the previous three chapters, and present the overall conclusions from the thesis.  I will 
then reiterate the research questions and hypotheses that were initially proposed in the 
introduction (see Section 1.6).  This is followed by a discussion of our proposed answers 
to those research questions.  Finally, I will motivate potential future research directions 
related to this work and our findings.  More specifically, future work that will: 1) 
demonstrate the improvements in PET quantitation with MVCT-based attenuation 
correction of various MRI hardware components in a clinical setting; and 2) further 
investigate the benefits of using 4D PET-MRI for clinical radiotherapy planning of 
tumours in sites impacted by respiratory motion. 
5.1 Techniques to Improve Accuracy of MRI Hardware 
Attenuation Maps in PET-MRI 
In the second chapter of this thesis, I implemented two different techniques to improve 
upon current methods of μ-map construction for MRI hardware containing dense 
materials used in PET-MRI.  The first technique used a DECT scan (80 kVp and 140 
kVp) of the MRI hardware (four-channel breast receive-only coil) to construct virtual 
monoenergetic image volumes, effectively reducing the amount of beam hardening 
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caused by dense materials such as metal.  The second technique used a tomotherapy 
linear accelerator to create CT images at megavoltage energies (1.0 MV) of the four-
channel breast coil.  In the megavoltage range, Compton scatter is the dominant photon 
interaction and better photon penetration through dense materials can be achieved.  Two 
scans of homogenous cylindrical phantoms were acquired.  The first scan was acquired in 
the presence of the breast coil, while the second acquisition was taken with the phantoms 
in a polystyrene rigid foam fixture, positioned identical to the breast coil.  Both μ-map 
construction techniques were compared to a previously published technique that 
calculated a hardware μ-map from a standard SECT at kilovoltage energies.  The DECT-
based technique reduced the amount of visible metal artefact streaking in the image 
volumes and this translated to improved accuracy of the μ-map.  This improvement was 
demonstrated in the DECT-based μ-map corrected PET volume, which showed improved 
homogeneity throughout the phantoms.  Although this technique improved on the SECT-
based method by reducing the effects of beam hardening, the virtual monoenergetic 
images from which the μ-maps are calculated were still subject to other sources of error 
(i.e. signal truncation, and noise from scattered radiation).  However, the MVCT-based 
technique improved further on the artefact reduction seen in the virtual monoenergetic 
image reconstructions from DECT.  The lack of visible artefacts in the MVCT images 
resulted in an artefact free μ-map, which facilitated a more accurate correction of PET 
photon attenuation from the breast coil.   
5.2 Development of a PET/MRI/CT-Compatible Tumour 
Respiratory Motion Phantom for Quality Assurance 
In Chapter 3, I designed a PET-MR-CT compatible respiratory motion phantom for 
quality assurance of motion-correction protocols in hybrid imaging modalities.  The all-
acrylic phantom had five compartments and was created to represent an average human 
torso with air cavities representing the lungs.  The main torso compartment contained 
three smaller cylinders running the full length of the torso – two compartments to 
represent the lungs and a single smaller compartment to represent a spine.  The two lung 
compartments are open at the inferior end of the torso to allow lesion-mimicking 
compartments to move freely inside while attached to the MRI compatible motion stage.1 
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In this study, lesions were simulated with four acrylic spheres (28 mm, 22 mm, 17 mm, 
and 10 mm internal diameters). I then used this phantom to evaluate the accuracy and 
sensitivity of a clinically available real-time dynamic MR images and a respiratory-
triggered PET-MRI protocol in detecting the lesions while moving at two different 
magnitudes of motion (peak-to-peak extent of 1.5 and 3 cm).  Displacement 
measurements of lesion centroids in dynamic MR images using the real-time balanced 
steady-state free precession sequence (TrueFISP),2 showed excellent correlation with 
known displacement values (r2 = 0.994 to 0.998 and r2 = 0.997 to 0.999 for 1.5 cm and 
3.0 cm displacement respectively).  The respiratory-triggered T2-weighted single-shot 
turbo spin echo sequence (BLADE)3 saw sphere diameter measurement increases in the 
direction of motion are between 1.2 and 3.8 mm for 1.5 cm of motion and 2.5 to 5.1 mm 
for 3.0 cm of motion.  These are within the maximum expected motion artefact values, 
once image sampling is taking into account.  PET images from data binned according to 
the respiratory-triggered MR acquisition resulted in a reduction in mean and maximum 
voxel intensities for both motion magnitudes when compared to static PET. Gated PET 
show a slight increase in lesion compartment volumes, due to residual smearing of PET 
activity during the gating window. Overall, the results show that both the respiratory-
triggered MRI and gated PET perform well under the motion conditions presented and 
allow for excellent co-registration of the modalities.  It was noted however, that the 
current breath-hold protocol used for acquiring and calculating MR-based MRAC maps 
may still pose a challenge for non-compliant patients. Additionally, it was found that the 
phantom developed for this study provides a good model for performing routine quality 
assurance of respiratory-triggered PET-MRI and as such was able to provide useful tool 
for the development of the technique presented in Chapter 4. 
5.3 Development of a 4D PET-MRI Protocol to 
Characterize Respiratory Motion 
Chapter 4 presents the description and results from evaluating a 4D-PET/MRI post-
processing technique, using MR sequences and PET acquisition methods that are already 
available on clinical hybrid PET/MRI systems.  This technique is validated using the 
programmable PET/MRI/CT compatible tumour respiratory motion phantom that was 
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developed and presented in Chapter 3 as a tool to evaluate a diagnostic PET/MRI lung 
protocol with motion correction. It was suggested in the discussion of Chapter 3 that, in 
addition to quality assurance measurements of existing protocols, my phantom could be 
used for protocol development. The work in Chapter 4 demonstrates the use of this 
phantom for the development of a 4D-PET/MRI technique.  
First, an MR-based μ-map was acquired with a T1-weighted two-point Dixon 3D 
volumetric interpolated breath-hold examination (VIBE) sequence,4 at the beginning of 
each acquisition.  This was followed by a dynamic 2D MR images of the phantom with 
moving lesion compartments were acquired in 53 adjacent coronal slices (50 per slice) 
using an ultrafast gradient echo pulse sequence (TurboFLASH).5 Dynamic PET data was 
also acquired in list-mode at a single bed position for the duration of the MR acquisitions 
(~ 12 min).  Using the data files from the motion stage as surrogate trace for sorting, 10 
respiratory phases were calculated by dividing the distance between the minimum and 
maximum respiratory amplitudes into 5 amplitude positions and then dividing those 
according to inspiration or expiration.  All 2D MR images and list-mode PET data were 
sorted into their respective bins according to this surrogate, resulting in 10 3D-MRI 
volumes and 10 list-mode PET files, one for each respiratory phase.  Each list-mode PET 
file was reconstructed into 10 PET image volumes.  Deformation fields were calculate 
between all phases using the newly constructed MRI volumes and then applied to the 
single-phase μ-map to produce a μ-map for each of the ten phases.  The deformation 
fields were also applied to each PET volume.  This allows all counts collected throughout 
the scan to be summed at each of the 10 phases, to improve image statistics.  As 
mentioned previously, our validation study used our torso phantom with four acrylic 
lesion compartment spheres (10, 17, 22, and 28mm).  The spheres were connected to an 
MR-compatible motion stage that was programmed with 3 different motion profiles (2 
irregular patient profiles and 1 sinusoidal pattern with a dwell at the bottom third of the 
cycle).  Both the torso and the spheres were filled with MRI fluid and 18F to mimic 
signals from a patient with lung lesions. Volumetric measurements of 17, 22, and 28 mm 
segmented spheres volumes in PET showed good agreement with known values in all 
4D-PET images.  4D-PET CNR values showed a slight improvement over the single gate 
reconstructions for 22 and 28 mm spheres and similar values to single gate for the 17 mm 
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sphere.  The 10 mm sphere showed poor and inconsistent values for all PET 
measurements.  This was due to a combination of segmentation method failure and 
inaccurate deformation field calculation between phases for the 10 mm sphere.  Centroid 
displacement measurements for all spheres in all 4D images showed excellent correlation 
with their ground truth positions in both A-P and S-I directions (r2 = 0.91 to 1.0, 0.91 to 
1.0, 0.92 to 1.0, and 0.85 to 1.0 for 28, 22, 17, and 10 mm spheres respectively). 
I conclude that our retrospective 4D-PET-MRI technique with attenuation 
correction is capable of providing information to characterize tumour respiratory motion 
while providing the added benefit of using a clinically available pulse sequence and PET 
acquisition method, eliminating the need for less available more exotic sequences or MR 
pulse sequence programming.  The hypothetical benefits of such a technique include 
adding complementary information about tumour molecular characteristics and soft-
tissue details of MRI to 4D-CT for radiotherapy planning in motion prone anatomy, such 
as lung and liver. 
5.4 Conclusions 
The overall goal of this thesis was to develop techniques to overcome two outstanding 
issues in hybrid PET-MRI: 1) Attenuation correction of MRI hardware composed of 
dense materials; 2) Quality assurance of motion correction protocols intended for 
radiotherapy treatment planning.  This goal was motivated by the following research 
questions: 
Q1   Can accurate μ-maps be derived from DECT and MVCT images of RF coils, for 
use in quantitative PET-MR imaging? 
Q2   Can a MR-PET compatible motion phantom be designed to evaluate the accuracy 
and PET sensitivity of respiratory-triggered PET-MRI protocols under controlled 
conditions? 
Q3   Can tumour respiratory motion be characterized using coregistered dynamic 3D 
MRI and PET volumes? 
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 Chapter 2 of the thesis addressed Q1.  The DECT-derived virtual monochromatic 
images noticeably reduced the beam hardening artefacts that were observed in the SECT 
images.  This led to improvements in μ-map accuracy, which is seen as increased 
homogeneity of PET activity in ROI measurements.  However, some metal artefacts 
remained due to projection truncation and/or photon starvation at lower energies of the 
two spectra, and threshold values were applied to the µ-map to remove the remaining 
artefacts.  The MVCT images did not contain any visible metal artefacts leading to an 
artefact-free µ-map, which did not require any other correction strategies to remove 
artefacts seen in µ-maps calculated from keV energy CT images. 
Q2 was addressed within chapter 3 of the thesis. By designing a PET-MRI compatible 
tumour respiratory motion phantom and then evaluating the accuracy and sensitivity of 
an already available clinical PET-MRI protocol with it, I was able to fulfill an unmet 
need for a programmable motion phantom for use in routine quality assurance of multi-
modality motion correction protocols.  
 In chapter 4 of the thesis, I addressed Q3.  I was able to use pre-existing PET and 
MRI imaging protocols, which are clinically available on hybrid PET-MRI systems, to 
develop a 4D-PET-MRI post processing technique.  This also eliminates the need for 
sequences that have limited availability or the need for MR pulse sequence 
programming. The imaging protocol developed and validated in this chapter can easily 
be translated into a patient specific imaging protocols for precision radiotherapy, where 
respiratory motion is a concern, including lung, esophageal, and liver cancer. 
5.5 Future Work 
5.5.1 MVCT-based μ-maps for Additional Hardware Components 
In addition to further validating the MVCT-based μ-map of the four-channel breast coil 
with patient datasets, this technique could be applied to other types of MRI hardware that 
typically will be required to be positioned within the PET field of view on hybrid PET-
MRI systems.  Previous work on correcting for PET attenuation of a head and neck coil 
found the lock, signal cables, connectors, and most of all the casing between both coils 
were all important sources of attenuation.6 A 17% loss of true counts due to its presence 
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was found, which is greater than the ~10% found with the breast coil. This may be a 
good application for our MVCT-based approach, along with other, more highly 
attenuating MR hardware. 
5.5.2 Development of Routine Quality Assurance Procedures 
The development of our tumour respiratory motion fulfills an unmet need for a 
programmable motion phantom that can be used for quality assurance of motion 
correction protocols, as well as protocol development.  Future work should involve the 
development of standard procedures for routine quality assurance of protocols to both 
ensure consistent accuracy of motion correction/characterization, as well as define 
functional limitations or constraints of such protocols.  Further refinement of the 
phantom design, including development of purpose specific lesion compartments to 
attach to the motion stage could broaden the phantom’s range of uses. 
5.5.3 Further Improvements to 4D-PET-MRI Technique 
As mentioned in Chapter 4, further improvements to the image registration technique 
improve the ability to characterize lesions smaller than 17 mm in diameter undergoing 
motion greater than 1.7 cm.  Brehm et al uses a cyclic registration technique for motion 
compensation and found it to outperform spatial registration using demons deformable 
registration algorithm for motion estimation to obtain the deformation fields between 
respiratory phases.7 This strategy may provide the desired improvements.  Dutta et al. 
also presented a motion compensated PET/MR technique that uses a novel radial 
navigated MR pulse sequence to construct up to 12 gates is used to calculate deformation 
fields between gates.8 This method proved effective at correcting motion of 10 mm 
pulmonary lesions in a simulation study.  Both of these techniques should be investigated 
further for their applications to 4D-PET-MRI.   
Additionally, exploring the optimization of MRI parameters to increase temporal 
resolution, and minimize effects to the signal-to-noise ratio and pixel size may allow 
more phase volumes to be constructed.  This could improve motion characterization, as 
well as minimize any need to supplement missing phase-slice images with their close 
approximations. 
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It is hoped that the tools and techniques developed in this thesis will expand the 
use of quantitative hybrid PET-MRI for radiotherapy planning, to improve conformality 
of dose to targets while reducing toxicity to healthy tissues, thereby positively 
influencing the standard of care for cancer patients.  
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